View:
As filed with the Securities and Exchange Commission on March 17, 1998
Registration No. 333-12073
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------
POST-EFFECTIVE AMENDMENT NO. 2 TO
FORM S-1 REGISTRATION STATEMENT (NO. 333-12073)
ON FORM S-3 REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
---------------
NU SKIN ASIA PACIFIC, INC.
(Exact Name of Registrant as Specified in Its Charter)
---------------
Delaware 5122 87-0565309
(State or Jurisdiction of (Primary Standard Industrial (I.R.S. Employer
Incorporation or Organization) Classification Code Number) Identification No.)
75 West Center Street
Provo, Utah 84601
(801) 345-6100
(Address, including zip code, and telephone number, including area
code, of registrant's principal executive offices)
Steven J. Lund, President
Nu Skin Asia Pacific, Inc.
75 West Center Street
Provo, Utah 84601
(801) 345-6100
(Name, and address, including zip code, and telephone number,
including area code, of agent for service)
---------------
Copies to:
Nolan S. Taylor, Esq. M. Truman Hunt, Esq.
LeBoeuf, Lamb, Greene & MacRae, L.L.P. Nu Skin Asia Pacific, Inc.
1000 Kearns Building 75 West Center Street
136 South Main Street Provo, Utah 84601
Salt Lake City, Utah 84101-1685 (801) 345-6100
(801) 320-6700
---------------
Approximate date of commencement of proposed sale to the public: As soon
as practicable after the effective date of this Registration Statement.
---------------
If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [ ]
If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. |X|
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
---------------
The Registrant hereby amends this Registration Statement on such date or
dates as may be necessary to delay its effective date until the Registrant shall
file a further amendment which specifically states that this Registration
Statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933 or until the Registration Statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a),
may determine.
- --------------------------------------------------------------------------------
Explanatory Note:
This post-effective amendment is intended, pursuant to Rule 429 of the
Securities and Exchange Commission to constitute a Post-Effective
Amendment No. 2 to Registration Statement No. 333-12073.
PROSPECTUS
3,030,000 Shares of Class A Common Stock
[LOGO]
-------------------------
This Prospectus relates to up to 3,030,000 shares of Class A Common Stock,
par value $.001 per share (the "Class A Common Stock"), of Nu Skin Asia Pacific,
Inc. ("Nu Skin Asia Pacific" or the "Company"), including the offering by the
Company of up to 1,605,000 shares of Class A Common Stock to be issued upon the
exercise of options held by distributors (the "Distributor Options") of Nu Skin
International, Inc. ("NSI"), an affiliate of the Company, the offering by the
Company to its employees of up to 175,000 shares of Class A Common Stock as
employee stock bonus awards and the offering by NSI and its affiliates (other
than the Company) (the "Rule 415 Selling Stockholders") of up to 1,250,000
shares of Class A Common Stock to their employees as employee stock bonus
awards. The offering of the shares of Class A Common Stock underlying the
Distributor Options and the employee stock bonus awards are collectively
referred to as the "Rule 415 Offerings." See "Rule 415 Selling Stockholders" and
"Plan of Distribution."
The Class A Common Stock may be offered from time to time directly by the
holders or pledgees, donees, transferees or other successors in interest.
Alternatively, the Class A Common Stock may be offered from time to time by the
holders or through brokers or dealers who may act solely as agents, or may
acquire shares as principals. The distribution of the Class A Common Stock may
be effected in one or more transactions that may take place on the New York
Stock Exchange, including block trades, ordinary brokers' transactions,
privately negotiated transactions or through sales to one or more broker/dealers
for resale of such securities as principals, at market prices prevailing at the
time of sale, at prices related to such prevailing market prices or at
negotiated prices. Usual and customary or specifically negotiated brokerage fees
or commissions may be paid by these holders in connection with such sales. In
connection with such sales, the holders and any participating brokers or dealers
may be deemed "underwriters" as such term is defined in the Securities Act of
1933, as amended (the "Securities Act"). See "Plan of Distribution."
Other than the exercise price of such Distributor Options as may be
exercised, the Company will not receive any of the proceeds from the Rule 415
Offerings. The gross proceeds from the issuance of shares of Class A Common
Stock by the Company in connection with the exercise of the Distributor Options
are estimated to be approximately $9.2 million (assuming the exercise of all
1,605,000 Distributor Options).
The Class A Common Stock is traded on the New York Stock Exchange under
the symbol "NUS." On March 11, 1998, the last reported sale price of the Class A
Common Stock was $ 24.56 per share.
See "Risk Factors" beginning on page 8 for a discussion of certain factors
which should be considered by prospective purchasers of the securities offered
hereby.
-------------------------
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION, NOR HAS
THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES
COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS
PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
-------------------------
The date of this Prospectus is March ___, 1998.
1
AVAILABLE INFORMATION
The Company has filed with the Securities and Exchange Commission (the
"Commission") a Registration Statement on Form S-3 (together with all amendments
and exhibits thereto, the "Registration Statement"), of which this Prospectus is
a part, under the Securities Act with respect to the shares of Class A Common
Stock offered hereby. This Prospectus does not contain all the information set
forth in the Registration Statement and the exhibits and schedules thereto,
certain portions of which have been omitted as permitted by the rules and
regulations of the Commission. For further information with respect to the
Company and the securities offered hereby, reference is made to the Registration
Statement, including the financial schedules and exhibits filed therewith, which
may be examined without charge at, or copies of which may be obtained upon
payment of prescribed fees from, the Commission and its regional offices listed
below. Statements made in this Prospectus as to the contents of any contract,
agreement or other documents are not necessarily complete, and, in each
instance, reference is made to the copy of such document filed as an exhibit to
the Registration Statement or otherwise with the Commission. Each such statement
shall be deemed qualified in its entirety by such reference.
The Company is subject to the informational requirements of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and in accordance
therewith files reports, proxy statements and other information with the
Commission. The Registration Statement and the exhibits thereto, as well as any
such reports, proxy statements and other information filed by the Company with
the Commission, may be inspected and copied at the public reference facilities
maintained by the Commission at Room 1024, 450 Fifth Street, N.W., Washington,
D.C. 20549, and at the Commission's regional offices at 7 World Trade Center,
Suite 1300, New York, New York 10048 and 500 West Madison Street, Suite 1400,
Chicago, Illinois 60661-2311. Copies of such material also may be obtained at
prescribed rates from the Public Reference Section of the Commission at 450
Fifth Street, N.W., Washington, D.C. 20549. The Commission also maintains a web
site at http:\\www.sec.gov which contains reports, proxy and information
statements and other information regarding issuers that file electronically with
the Commission. Such reports and other information may also be inspected at the
offices of the New York Stock Exchange, 20 Broad Street, New York, New York
10005.
INCORPORATION BY REFERENCE
The following documents have been filed with the Commission and are
incorporated by reference in this Prospectus:
(1) The Company's Annual Report on Form 10-K for the year ended December
31, 1997; and
(2) The description of the Company's Class A Common Stock as contained in
the Company's Registration Statement on Form 8-A dated November 6,
1996.
All documents and reports filed by the Company pursuant to Section 13(a),
13(c), 14 or 15(d) of the Exchange Act after the date hereof and prior to the
termination of the offering shall be deemed to be incorporated by reference into
this Prospectus and to be a part hereof from the date of filing of such
documents. Any statement contained in a document incorporated or deemed to be
incorporated by reference herein shall be deemed to be modified or superseded
for purposes of this Prospectus to the extent that a statement contained herein
or in any subsequently filed document which is deemed to be incorporated by
reference herein modifies or supersedes such statement. Any statement so
modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this Prospectus.
The Company will furnish without charge, upon written or oral request, to
each person, including any beneficial owner, to whom this Prospectus is
delivered, a copy of any or all of the documents incorporated by
2
reference herein other than exhibits to such documents (unless such exhibits are
specifically incorporated by reference into such documents). Requests for
documents should be directed to Nu Skin Asia Pacific, Inc., 75 West Center,
Provo, UT 84601, Attention: Investor Relations, telephone number (801) 345-6100.
FORWARD-LOOKING STATEMENTS
Certain statements made herein are "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform
Act"). In addition, when used in this Prospectus and the documents incorporated
herein by reference, the words or phrases "will likely result," "expects,"
"intends," "will continue," "is anticipated," "estimates," "projects" and
similar expressions are intended to identify "forward-looking statements" within
the meaning of the Reform Act. Forward-looking statements include plans and
objectives of management for future operations, including plans and objectives
relating to the products and the future economic performance and financial
results of the Company. The forward-looking statements and associated risks set
forth or incorporated by reference herein relate to the: (i) proposed
acquisition of NSI and certain of its affiliates; (ii) expansion of the
Company's market share in its current markets; (iii) Company's entrance into new
markets; (iv) development of new products and new product lines tailored to
appeal to the particular needs of consumers in specific markets; (v) stimulation
of product sales by introducing new products; (vi) opening of new offices,
walk-in distribution centers and distributor support centers in certain markets;
(vii) promotion of distributor growth, retention and leadership through local
initiatives; (viii) upgrading of the Company's technological resources to
support distributors; (ix) obtaining of regulatory approvals for certain
products, including LifePak; (x) stimulation of product purchases by inactive
distributors through direct mail campaigns; (xi) retention of the Company's
earnings for use in the operation and expansion of the Company's business; (xii)
development of brand awareness and loyalty; (xiii) enhancing of the Company's
Global Compensation Plan (as defined herein); (xiv) diversifying of the
Company's revenue base and markets, (xv) seeking of cost reductions from
vendors; and (vxi) establishment of local manufacturing. All forward-looking
statements involve predictions and are subject to known and unknown risks and
uncertainties, including, without limitation, those discussed under the caption
"Risk Factors" as well as general economic and business conditions, that could
cause actual results to differ materially from historical earnings and those
presently anticipated or projected. Readers should not place undue reliance on
any such forward-looking statements, which speak only as of the date made. The
factors listed under the caption "Risk Factors" could affect the Company's
financial performance and could cause the Company's actual results for future
periods to differ materially from any opinions or statements expressed with
respect to future periods in any current statements. Factors and risks that
might cause such differences include, but are not limited to, (a) factors
related to the Company's reliance upon independent distributors of NSI, (b)
fluctuations in foreign currency values relative to the U.S. dollar, (c) adverse
economic and business conditions in the Company's markets, especially South
Korea and Thailand, (d) the possibility that the proposed acquisition of NSI and
certain of its affiliates may not be consummated, (e) the potential effects of
adverse publicity, including adverse publicity regarding the Company and other
direct selling companies in South Korea and the Company's other markets, (f) the
potential negative impact of distributor actions, (g) seasonal and cyclical
trends, (h) variations in operating results, (i) government regulation of direct
selling activities in the PRC (as defined herein), Malaysia and other existing
and future markets, (j) government regulation of products and marketing, (k)
import restrictions, (l) other regulatory issues, including regulatory action
against the Company or its distributors in any of the Company's markets and
particularly in South Korea, (m) the Company's reliance on certain distributors,
(n) the potential divergence of interests between distributors and the Company,
(o) management of the Company's growth, (p) the effects on operations of the NSI
distributor equity program, (q) the introduction of the Scion product line in
the Philippines and Aloe-mx in Japan, (r) market acceptance in South Korea and
other markets of LifePak, the Company's core IDN product, (s) the acceptance of
new distributor walk-in centers in Japan, Thailand and Taiwan, (t) acceptance of
modifications to the Company's sales compensation plan in the Philippines, (u)
the Company's ability to renegotiate or adjust vendor relationships, (v) the
Company's ability to establish local manufacturing capability, (w) risks
inherent in the importation, regulation and sale of personal care and
nutritional products in
3
the Company's markets, (x) the Company's ability to successfully enter new
markets such as Poland and Brazil and introduce new products in addition to
those already referenced above, (y) the Company's ability to manage growth and
deal with the possible adverse effect on the Company of the change in the status
of Hong Kong, (z) the potential conflicts of interest between the Company and
NSI, (aa) control of the Company by the Original Stockholders (as defined
herein), (bb) the anti-takeover effects of dual classes of common stock, (cc)
the Company's reliance on and the concentration of outside manufacturers, (dd)
the Company's reliance on the operations of and dividends and distributions from
the Subsidiaries, (ee) taxation and transfer pricing issues, (ff) the potential
increase in distributor compensation expense, (gg) product liability issues and
(hh) competition in the Company's existing and future markets. In light of the
significant uncertainties inherent in forward-looking statements, the inclusion
of any such statement should not be regarded as a representation by the Company
or any other person that the objectives or plans of the Company will be
achieved. The Company disclaims any obligation or intent to update any such
factors or forward-looking statements to reflect future events or developments.
See "Risk Factors."
THE COMPANY
Nu Skin Asia Pacific is a rapidly growing network marketing company
involved in the distribution and sale of premium quality, innovative personal
care and nutritional products. The Company is the exclusive distribution vehicle
for NSI in the countries of Japan, Taiwan, Hong Kong (including Macau), South
Korea, Thailand and the Philippines, where the Company currently has operations,
and in Indonesia, Malaysia, the People's Republic of China ("PRC"), Singapore
and Vietnam, where Nu Skin operations have not commenced. The Company's products
are specifically designed for the network marketing distribution channel. The
Company markets its personal care products under the trademark "Nu Skin" and its
nutritional products under the trademark "Interior Design Nutritionals" ("IDN").
The Nu Skin personal care product lines include facial care, body care, hair
care and color cosmetics, as well as specialty products such as sun protection,
oral hygiene and fragrances. The IDN product lines include nutritional
supplements, nutritious and healthy snacks, sports and fitness nutritional
products, health solutions and botanical supplements.
In Japan, Taiwan and Hong Kong, the Company currently offers most of the
Nu Skin personal care products and approximately one-third of the IDN products,
including LifePak, one of the core IDN nutritional supplements. In South Korea,
the Company currently offers approximately one-half of the Nu Skin personal care
products, including most of the Nu Skin core facial and hair care products, and
LifePak. In Thailand and the Philippines, the Company currently offers one-third
of the Nu Skin personal care products, including most of the core facial and
hair care products, and none of the nutritional products. The Company believes
that it can significantly grow its business and attract new customers by
expanding its product offerings in each of its markets to include more of the
existing Nu Skin personal care and IDN products. In addition to expanding its
product offerings with existing Nu Skin personal care and IDN products, the
Company intends to introduce new products tailored to specific markets.
The Company believes it is one of the fastest growing network marketing
companies in Asia. Revenue increased 31.2% to $890.5 million for the year ended
December 31, 1997 from $678.6 million in 1996. Operating expenses have increased
with the growth of the Company's revenue. Net income increased 14.6% to $93.6
million for the year ended December 31, 1997 from $81.7 million in 1996. The
Company's network of independent distributors has grown since the Company's
inception in 1991 to more than 430,000 active distributors as of March 5, 1998.
See "Risk Factors--Managing Growth."
A great deal of the Company's success to date is the result of the growth
of its Japanese business, which can be attributed in part to an increasing
awareness of the Nu Skin and IDN brands. Significant revenue was recognized from
the outset of the Company's operations in Japan in 1993 due to the immediate
attention given to
4
the market by leading NSI distributors from around the world. Japan has
continued to post strong financial results for the Company, with revenue
increasing by approximately 58% in U.S. dollars and 75% in local currency for
1997 compared to 1996 and by approximately 64% in U.S. dollars and 90% in local
currency compared to 1995. Given the size of the direct selling market in Japan,
management believes that there is still significant opportunity for revenue
growth in this market.
NSI, founded in 1984, is engaged in selling personal care and nutritional
products and, together with its affiliates, comprises one of the largest network
marketing organizations in the world. NSI provides a high level of support
services to the Company, including product development, distributor support
services, marketing and other managerial support services. Management believes
that the Company's relationship with NSI has allowed the Company to increase
revenue and net income at rates that otherwise may not have been possible. See
"Risk Factors--Relationship with and Reliance on NSI; Potential Conflicts of
Interest." On February 27, 1998, the Company entered into a Stock Acquisition
Agreement with the stockholders of NSI and certain affiliates of NSI to acquire
all of the capital stock of NSI and certain affiliates of NSI. See "Recent
Developments."
The Company was incorporated on September 4, 1996. On November 20, 1996,
the stockholders (the "Original Stockholders") of Nu Skin Japan Company, Limited
("Nu Skin Japan"), Nu Skin Taiwan, Inc. ("Nu Skin Taiwan"), Nu Skin Hong Kong,
Inc. ("Nu Skin Hong Kong"), Nu Skin Korea, Inc. ("Nu Skin Korea") and Nu Skin
Personal Care (Thailand), Inc. ("Nu Skin Thailand") contributed their shares of
capital stock to the capital of the Company in exchange for shares of Class B
Common Stock, par value $.001 per share (the "Class B Common Stock"), of the
Company (the "Reorganization"). As a result of the Reorganization, each of the
above-listed companies became a wholly-owned subsidiary of the Company, and,
together with Nu Skin Philippines, Inc., are referred to collectively as the
"Subsidiaries." As used herein, "Nu Skin Asia Pacific" or the "Company" means Nu
Skin Asia Pacific, Inc. and the Subsidiaries, collectively.
The Company's principal executive offices are located at 75 West Center
Street, Provo, Utah 84601, and its telephone number is (801) 345-6100. Nu
Skin(R), Interior Design Nutritionals(TM), IDN(R), a logo consisting of an image
of a gold fountain with the words "Nu Skin" below it, and a logo consisting of
the stylized letters "IDN" in black and red are trademarks on NSI which are
licensed to the Company. The italicized product names used in this Prospectus
are product names and also, in certain cases, trademarks and are the property of
NSI. All other tradenames and trademarks appearing in this Prospectus are the
property of their respective holders.
RECENT DEVELOPMENTS
On February 27, 1998, the Company entered into a Stock Acquisition
Agreement (the "Acquisition Agreement") with the stockholders of NSI and certain
affiliates of NSI (the "NSI Stockholders") to acquire (the "NSI Acquisition")
all of the capital stock of NSI and certain affiliates of NSI (the "Acquired
Entities"). The consideration to be paid by the Company to the NSI Stockholders
will consist of shares of Series A Preferred Stock, par value $.001 per share,
of the Company (the "Series A Preferred Stock") in an amount determined as set
forth below, the assumption of the Acquired Entities' S Distribution Notes (as
defined below) payable to the NSI Stockholders in the amount of approximately
$180.0 million (taking into account the Acquired Entities' S Distribution Notes
in the amount of $136.2 million as of December 31, 1997 and additional Acquired
Entities' S Distribution Notes covering undistributed earnings for the period
commencing January 1, 1998 and ending on the closing date of the NSI
Acquisition) and, contingent upon NSI and the Company meeting certain earnings
growth targets, up to $25 million in cash per year over the next four years. In
addition, the Acquisition Agreement provides that if the Acquired Entities' S
Distribution Notes for the above-referenced periods do not equal or exceed
$180.0 million, the Company will pay each NSI Stockholder in cash or in the form
of promissory notes the difference between (i) $180.0 million and (ii) the
aggregate principal amount of the Acquired Entities' S Distribution Notes
multiplied by each NSI Stockholder's proportional ownership interest in the
outstanding capital stock of NSI. The Acquisition Agreement provides that the
number of shares of Series A Preferred Stock to be delivered to the NSI
Stockholders shall be determined by dividing $70 million by the average closing
price of the Class A Common Stock for the 20 consecutive trading days ending
five trading days prior to the closing of the NSI Acquisition.
5
Collectively, the NSI Stockholders and their affiliates own beneficially
all of the outstanding shares of the Class B Common Stock. In addition, several
of the NSI Stockholders are directors and/or executive officers of the Company.
Effective as of December 31, 1997, NSI contributed certain assets relating
to the right to distribute NSI products in the United States to Nu Skin USA,
Inc. ("Nu Skin USA"), a newly created corporation wholly owned by the NSI
Stockholders, in exchange for all of the common stock of Nu Skin USA. The Nu
Skin USA common stock was then distributed to the NSI Stockholders. In addition,
effective as of December 31, 1997, NSI and the other Acquired Entities declared
distributions to their then existing stockholders (consisting solely of the NSI
Stockholders) that included all of such Acquired Entities' previously earned and
undistributed S corporation earnings through such date (the "Acquired Entities'
S Corporation Distribution"). As of December 31, 1997, such Acquired Entities'
aggregate undistributed S corporation earnings were approximately $136.2
million. The Acquired Entities' S Corporation Distribution was distributed in
the form of promissory notes due December 31, 2004 and bearing interest at 8.0%
per annum (the "Acquired Entities' S Distribution Notes"). The Acquired
Entities' S Corporation Distribution Notes are held entirely by the NSI
Stockholders. In addition, the Acquired Entities will declare distributions to
then existing stockholders that include all of such Acquired Entities'
previously earned and undistributed S corporation earnings through the date of
closing of the NSI Acquisition. As discussed above, the obligation to repay the
Acquired Entities' S Distribution Notes to the NSI Stockholders will be assumed
by the Company in connection with the NSI Acquisition.
The Acquired Entities consist of NSI, Nu Skin International Management
Group, Inc., ("NSIMG") and the NSI affiliates operating in Europe, Australia and
New Zealand, including Nu Skin Europe, Inc.; Nu Skin U.K., Ltd. (domesticated in
Delaware under the name Nu Skin U.K., Inc.); Nu Skin Germany, GmbH (domesticated
in Delaware under the name Nu Skin Germany, Inc.); Nu Skin France, SARL
(domesticated in Delaware under the name Nu Skin France, Inc.); Nu Skin
Netherlands, B.V. (domesticated in Delaware under the name Nu Skin Netherlands,
Inc.); Nu Skin Italy, (SRL) (domesticated in Delaware under the name Nu Skin
Italy, Inc.); Nu Skin Spain, S.L. (domesticated in Delaware under the name Nu
Skin Spain, Inc.); Nu Skin Belgium, N.V. (domesticated in Delaware under the
name Nu Skin Belgium, Inc.); Nu Skin Personal Care Australia, Inc.; Nu Skin New
Zealand, Inc.; Nu Skin Brazil, Ltda. (domesticated in Delaware under the name Nu
Skin Brazil, Inc.); Nu Skin Argentina, Inc.; Nu Skin Chile, S.A. (domesticated
in Delaware under the name Nu Skin Chile, Inc.); Nu Skin Poland Spa.
(domesticated in Delaware under the name Nu Skin Poland, Inc.); and Cedar
Meadows, L.C. The NSI Stockholders continue to own as private entities the NSI
affiliates operating in the United States, Canada, Mexico, Guatemala and Puerto
Rico, including Nu Skin USA, Inc.; Nu Skin Canada, Inc.; Nu Skin Mexico S.A. de
C.V. (domesticated in Delaware under the name Nu Skin Mexico, Inc.); Nu Skin
Guatemala, S.A. (domesticated in Delaware under the name Nu Skin Guatemala,
Inc.); and Nu Skin Puerto Rico, Inc. (collectively, the "Retained Entities").
6
The following chart illustrates the organizational structure of the
Company and the Retained Entities immediately after the NSI Acquisition.
[ORGANIZATIONAL CHART]
Through its acquisition of NSI, the Company will obtain ownership and
control of the Nu Skin trademarks and tradenames, the Nu Skin Global
Compensation Plan, distributor lists and related intellectual property and
know-how (collectively, the "Intellectual Property"). The Company, through NSI,
intends to continue to license the Intellectual Property and, through NSIMG,
intends to continue to provide management support services to the Acquired
Entities on substantially the same terms as existed prior to the NSI
Acquisition. In connection with the NSI Acquisition, the Company anticipates,
through NSI and NSIMG, entering into new agreements with Nu Skin USA, Inc. and
revised agreements with the other Retained Entities on terms substantially
similar to its agreements with the Acquired Entities, pursuant to which NSI will
continue to license the Intellectual Property and the exclusive right to sell Nu
Skin personal care and nutritional products in the United States, Canada,
Mexico, Guatemala and Puerto Rico to the Retained Entities and NSIMG will
continue to provide management support services to the Retained Entities.
Upon completion of the NSI Acquisition, the Company and its subsidiaries
will own and distribute Nu Skin products in 18 markets worldwide. The Company
will also hold the rights to all future Nu Skin markets.
7
RISK FACTORS
An investment in the Class A Common Stock offered hereby involves special
considerations and significant risks, including, but not limited to, those
discussed or referred to below. Prospective investors should carefully consider
the following risks and information in conjunction with the other information
contained in this Prospectus before acquiring shares of Class A Common Stock.
The risk factors set forth below relate to the Company's business prior to the
contemplated NSI Acquisition. Certain of these factors may be impacted by the
proposed NSI Acquisition; however, no assurance can be given that the NSI
Acquisition will be consummated. See "Recent Developments."
Reliance Upon Independent Distributors of NSI
The Company distributes its products exclusively through independent
distributors who have contracted directly with NSI to become distributors.
Consequently, the Company does not contract directly with distributors but
licenses its distribution system and distributor force from NSI. Distributor
agreements with NSI are voluntarily terminable by distributors at any time. The
Company's revenue is directly dependent upon the efforts of these independent
distributors, and any growth in future sales volume will require an increase in
the productivity of these distributors and/or growth in the total number of
distributors. As is typical in the direct selling industry, there is turnover in
distributors from year to year, which requires the sponsoring and training of
new distributors by existing distributors to maintain or increase the overall
distributor force and motivate new and existing distributors. The Company
experiences seasonal decreases in distributor sponsoring and product sales in
some of the countries in which the Company operates because of local holidays
and customary vacation periods. The size of the distribution force can also be
particularly impacted by general economic and business conditions and a number
of intangible factors such as adverse publicity regarding the Company or NSI, or
the public's perception of the Company's products, product ingredients, NSI's
distributors or direct selling businesses in general. Historically, the Company
has experienced periodic fluctuations in the level of distributor sponsorship
(as measured by distributor applications). However, because of the number of
factors that impact the sponsoring of new distributors, and the fact that the
Company has little control over the level of sponsorship of new distributors,
the Company cannot predict the timing or degree of those fluctuations. There can
be no assurance that the number or productivity of the Company's distributors
will be sustained at current levels or increased in the future. In addition, the
number of distributors as a percentage of the population in a given country or
market could theoretically reach levels that become difficult to exceed due to
the finite number of persons inclined to pursue a direct selling business
opportunity. This is of particular concern in Taiwan, where industry sources
have estimated that up to 10% of the population is already involved in some form
of direct selling.
Since distributor agreements are entered into between NSI and
distributors, all of the distributors who generate revenue for the Company are
distributors of NSI. See "--Relationship with and Reliance on NSI; Potential
Conflicts of Interest." Because distributors are independent contractors of NSI,
neither NSI nor the Company is in a position to provide the same level of
direction, motivation and oversight as either would with respect to its own
employees. The Company relies on NSI to enforce distributors policies and
procedures. Although NSI has a compliance department responsible for the
enforcement of the policies and procedures that govern distributor conduct, it
can be difficult to enforce these policies and procedures because of the large
number of distributors and their independent status, as well as the impact of
regulations in certain countries that limit the ability of NSI and the Company
to monitor and control the sales practices of distributors.
Currency Risks
The Company's foreign-derived sales and selling, general and
administrative expenses are converted to U.S. dollars for reporting purposes.
Consequently, the Company's reported earnings are significantly impacted by
changes in currency exchange rates, generally increasing with a weakening dollar
and decreasing with a strengthening dollar. In addition, the Company purchases
inventory from NSI in U.S. dollars and assumes currency exchange rate risk with
respect to such purchases. Local currency in Japan, Taiwan, Hong Kong, South
8
Korea, Thailand and the Philippines is generally used to settle non-inventory
transactions with NSI. Given the uncertainty of the extent of exchange rate
fluctuations, the Company cannot estimate the effect of these fluctuations on
its future business, product pricing, results of operations or financial
condition. However, because nearly all of the Company's revenue is realized in
local currencies and the majority of its cost of sales is denominated in U.S.
dollars, the Company's gross profits will be positively affected by a weakening
in the U.S. dollar and will be negatively affected by a strengthening in the
U.S. dollar.
The Company believes that a variety of complex factors impact the value of
local currencies relative to the U.S. dollar including, without limitation,
interest rates, monetary policies, political environments, and relative economic
strengths. The Company has been subject to exceptionally high volatility in
currency exchange rates in certain markets during 1997. In order to partially
offset the anticipated effect of these currency fluctuations, the Company
implemented a price increase on certain of its products of between 5% and 9% on
average in 1997. There can be no assurance that future currency fluctuations
will not result in similar concerns or adversely affect the performance of the
price of the Class A Common Stock. Although the Company tries to reduce its
exposure to fluctuations in foreign exchange rates by using hedging
transactions, such transactions may not entirely offset the impact of currency
fluctuations. Accordingly, in the face of a strengthening of the U.S. dollar,
the Company's earnings will be adversely affected. The Company does not use
hedging transactions for trading or speculative purposes.
Risks Related to the Proposed NSI Acquisition
The Company believes that the proposed NSI Acquisition will offer
opportunities for long-term efficiencies in operations that should positively
affect future results of the combined operations of the Company and the Acquired
Entities. However, no assurances can be given whether or when such efficiencies
will be realized. In addition, the combined companies will be more complex and
diverse than the Company individually, and the combination and continued
operation of their distinct business operations will present difficult
challenges for the Company's management due to the increased time and resources
required in the management effort. While management and the Board of Directors
of the Company believe that the combination can be effected in a manner which
will increase the value of the Company and the Acquired Entities, no assurance
can given that such realization of value will be achieved.
Although the parties to the NSI Acquisition have entered into definitive
agreements, the closing of the NSI Acquisition is subject to the timely
satisfaction of certain conditions contained in the Acquisition Agreement.
Although the Company currently expects that such closing conditions will be
satisfied or waived, there can be no assurance that the closing of the NSI
Acquisition will occur. Such conditions include, among others, the receipt of an
opinion from the Company's independent public accountants with respect to
certain tax matters of the NSI Acquisition, the receipt of all necessary
consents and approvals from governmental officials and other third parties and
the absence of any material adverse change in the business or operations of the
Acquired Entities.
Potential Effects of Adverse Publicity
The size of the distribution force and the results of the Company's
operations can be particularly impacted by adverse publicity regarding the
Company or NSI, or their competitors, including publicity regarding the legality
of network marketing, the quality of the Company's products and product
ingredients or those of its competitors, regulatory investigations of the
Company or the Company's competitors and their products, distributor actions and
the public's perception of NSI's distributors and direct selling businesses
generally.
In 1991 and 1992, NSI was the subject of investigations by various
regulatory agencies of eight states. All of the investigations were concluded
satisfactorily. However, the publicity associated with the investigations
resulted in a material adverse impact on NSI's results of operations. The denial
by the Malaysian government in 1995 of the Company's business permit
applications due to distributor actions resulted in adverse publicity for the
Company. See"--Potential Negative Impact of Distributor Actions." In South
Korea, publicity generated by a
9
coalition of consumer groups targeted at a competitor of the Company negatively
impacted the Company's operations in 1997. In addition, the South Korean
government and certain consumer and trade organizations have expressed concerns
which have attracted media attention regarding South Korean consumption of
luxury and foreign products, in general. The Company believes that the adverse
publicity resulting from these claims and media campaigns has adversely affected
and may continue to adversely affect the direct selling industry and the
Company's South Korean operations. See "--Seasonality and Cyclicality;
Variations in Operating Results." The State of Pennsylvania recently filed an
action against NSI for alleged violations of Pennsylvania law relating to
activities of Nu Skin distributors promoting a business called Big Planet. The
filing of the action precipitated certain negative media coverage just may have
an impact on the operations of the Company and its affiliates. There can be no
assurance that the Company will not be subject to adverse publicity in the
future as a result of regulatory investigations or actions, whether of the
Company or its competitors, distributor actions, actions of competitors or other
factors, or that such adverse publicity will not have a material adverse effect
on the Company's business or results of operations. See "--Government Regulation
of Direct Selling Activities," "--Government Regulation of Products and
Marketing; Import Restrictions," "--Other Regulatory Issues" and "--Entering New
Markets."
Potential Negative Impact of Distributor Actions
Distributor actions can negatively impact the Company and its products.
From time to time, the Company receives inquiries from regulatory agencies
precipitated by distributor actions. For example, in October 1995, the Company's
business permit applications were denied by the Malaysian government as the
result of activities by certain NSI distributors before required government
approvals could be secured. NSI subsequently terminated the distributorship
rights of some of the distributors involved and elected to withdraw from the
Malaysian market for a period of time. The denial by the Malaysian government of
the Company's business permit applications resulted in adverse publicity for the
Company. See "--Other Regulatory Issues." Distributor activities in other
countries in which the Company has not commenced operations may similarly result
in an inability to secure, or delay in securing, required regulatory and
business permits. In addition, the publicity which can result from a variety of
potential distributor activities such as inappropriate earnings claims, product
representations or improper importation of Nu Skin products from other markets,
can make the sponsoring and retaining of distributors more difficult, thereby
negatively impacting sales. See "--Potential Effects of Adverse Publicity."
Furthermore, the Company's business and results of operations could be adversely
affected if NSI terminates a significant number of distributors or certain
distributors who play a key role in the Company's distribution system. There can
be no assurance that these or other distributor actions will not have a material
adverse effect on the Company's business or results of operations. The recent
action filed by the State of Pennsylvania against the Company resulted from
improper distributor actions. See "--Potential Effects of Adverse Publicity."
Seasonality and Cyclicality; Variations in Operating Results
While neither seasonal nor cyclical variations have materially affected
the Company's results of operations to date, the Company believes that its rapid
growth may have overshadowed these factors. Accordingly, there can be no
assurance that seasonal or cyclical variations will not materially adversely
affect the Company's results of operations in the future.
The direct selling industry in Asia is impacted by certain seasonal trends
such as major cultural events and vacation patterns. For example, sales are
generally affected by local New Year celebrations in Japan, Taiwan, Hong Kong,
South Korea and Thailand, which occur in the Company's first quarter. Management
believes that direct selling in Japan is also generally negatively impacted
during August, when many individuals traditionally take vacations.
Generally, the Company has experienced rapid revenue growth in each new
market from the commencement of operations. In Japan, Taiwan and Hong Kong, the
initial rapid revenue growth was followed by a short period of stable or
declining revenue followed by renewed growth fueled by new product
introductions,
10
an increase in the number of active distributors and increased distributor
productivity. The Company's operations in South Korea experienced a significant
decline in 1997 which was due in part to a business cycle common to new markets
opened by the Company but which was due primarily to general economic turmoil
and adverse business conditions. See "--Potential Effects of Adverse Publicity."
An additional factor which the Company believes has contributed to revenue
decline in South Korea is the focus of key distributors on other recently-opened
markets, including Thailand.
In addition, the Company may experience variations in its results of
operations, on a quarterly basis as new products are introduced and new markets
are opened. There can be no assurance that current revenue and productivity
trends will be maintained in any of these markets or that future results of
operations will follow historical performance.
Government Regulation of Direct Selling Activities
Direct selling activities are regulated by various governmental agencies.
These laws and regulations are generally intended to prevent fraudulent or
deceptive schemes, often referred to as "pyramid" or "chain sales" schemes, that
promise quick rewards for little or no effort, require high entry costs, use
high pressure recruiting methods and/or do not involve legitimate products. In
Japan, the Company's distribution system is regulated under the "Door-to-Door"
Sales Law, which requires the submission of specific information concerning the
Company's business and products and which provides certain cancellation and
cooling-off rights for consumers and new distributors. Management has been
advised by counsel that in some respects Japanese laws are becoming more
restrictive with respect to direct selling in Japan. In Taiwan, the Fair Trade
Law (and the Enforcement Rules and Supervisory Regulations of Multi-Level Sales)
requires the Company to comply with registration procedures and also provides
distributors with certain rights regarding cooling-off periods and product
returns. The Company also complies with South Korea's strict Door-to-Door Sales
Act, which requires, among other things, the regular reporting of revenue, the
registration of distributors together with the issuance of a registration card,
and the maintaining of a current distributor registry. This law also limits the
amount of commissions that a registered multi-level marketing company can pay to
its distributors to 35% of revenue in a given month. In Thailand and the
Philippines, general fair trade laws impact direct selling and multi-level
marketing activities.
Based on research conducted in opening its existing markets (including
assistance from local counsel), the nature and scope of inquiries from
government regulatory authorities and the Company's history of operations in
such markets to date, the Company believes that its method of distribution is in
compliance in all material respects with the laws and regulations relating to
direct selling activities of all of the countries in which the Company currently
operates. Many countries, however, including Singapore, one of the Company's
potential markets, currently have laws in place that would prohibit the Company
and NSI from conducting business in such markets. There can be no assurance that
the Company will be allowed to conduct business in each of the new markets or
continue to conduct business in each of its existing markets licensed from NSI.
See "--Entering New Markets."
Government Regulation of Products and Marketing; Import Restrictions
The Company and NSI are subject to or affected by extensive governmental
regulations not specifically addressed to network marketing. Such regulations
govern, among other things, (i) product formulation, labeling, packaging and
importation, (ii) product claims and advertising, whether made by the Company,
NSI or NSI distributors, (iii) fair trade and distributor practices, (iv) taxes,
transfer pricing and similar regulations that affect foreign taxable income and
customs duties, and (v) regulations governing foreign companies generally.
With the exception of a small percentage of revenues in Japan, virtually
all of the Company's sales historically have been derived from products
purchased from NSI. All of those products historically have been imported into
the countries in which they were ultimately sold. The countries in which the
Company currently conducts business impose various legal restrictions on
imports. In Japan, the Japanese Ministry of Health and Welfare ("MOHW") requires
the Company to possess an import business license and to register each personal
care
11
product imported into the country. Packaging and labeling requirements are also
specified. The Company has had to reformulate many products to satisfy MOHW
regulations. In Japan, nutritional foods, drugs and quasi-drugs are all strictly
regulated. The chief concern involves the types of claims and representations
that can be made regarding the efficacy of nutritional products. In Taiwan, all
"medicated" cosmetic and pharmaceutical products require registration. In Hong
Kong and Macau, "pharmaceutical" products are strictly regulated. In South
Korea, the Company is subject to and has obtained the mandatory certificate of
confirmation as a qualified importer of cosmetics under the Pharmaceutical
Affairs Law as well as additional product approvals for each of the 45
categories of cosmetic products which it imports. Each new cosmetic product
undergoes a 60-day post-customs inspection during which, in addition to
compliance with ingredient requirements, each product is inspected for
compliance with South Korean labeling requirements. In Thailand, personal care
products are regulated by the Food and Drug Association and the Ministry of
Public Health and all of the Nu Skin personal care products introduced in this
market have qualified for simplified approval procedures under Thai law. In the
Philippines, Nu Skin products are regulated by the Bureau of Food and Drug and
all products introduced in this market have been registered. There can be no
assurance that these or other applicable regulations will not prevent the
Company from introducing new products into its markets or require the
reformulation of existing products.
The Company has not experienced any difficulty maintaining its import
licenses but has experienced complications regarding health and safety and food
and drug regulations for nutritional products. Many products require
reformulation to comply with local requirements. In addition, new regulations
could be adopted or any of the existing regulations could be changed at any time
in a manner that could have a material adverse effect on the Company's business
and results of operations. Duties on imports are a component of national trade
and economic policy and could be changed in a manner that would be materially
adverse to the Company's sales and its competitive position compared to
locally-produced goods, in particular in countries such as Taiwan, where the
Company's products are already subject to high customs duties. In addition,
import restrictions in certain countries and jurisdictions limit the Company's
ability to import products from NSI. In some jurisdictions, such as the PRC,
regulators may prevent the importation of Nu Skin and IDN products altogether.
Present or future health and safety or food and drug regulations could delay or
prevent the introduction of new products into a given country or marketplace or
suspend or prohibit the sale of existing products in such country or
marketplace.
Other Regulatory Issues
As a U.S. entity operating through subsidiaries in foreign jurisdictions,
the Company is subject to foreign exchange control and transfer pricing laws
that regulate the flow of funds between the Subsidiaries and the Company, as
well as the flow of funds to NSI for product purchases, management services and
contractual obligations such as payment of distributor commissions. The Company
believes that it operates in compliance with all applicable customs, foreign
exchange control and transfer pricing laws. However, there can be no assurance
that the Company will continue to be found to be operating in compliance with
foreign customs, exchange control and transfer pricing laws, or that such laws
will not be modified, which, as a result, may require changes in the Company's
operating procedures.
As is the case with most network marketing companies, NSI and the Company
have from time to time received inquiries from various government regulatory
authorities regarding the nature of their business and other issues such as
compliance with local business opportunity and securities laws. Although to date
none of these inquiries has resulted in a finding materially adverse to the
Company or NSI, adverse publicity resulting from inquiries into NSI operations
by certain government agencies in the early 1990's, stemming in part out of
inappropriate product and earnings claims by distributors, materially adversely
affected NSI's business and results of operations. There can be no assurance
that the Company or NSI will not face similar inquiries in the future which,
either as a result of findings adverse to the Company or NSI or as a result of
adverse publicity resulting from the instigation of such inquiries, could have a
material adverse effect on the Company's business and results of operations. See
"--Potential Effects of Adverse Publicity."
12
The Subsidiaries are periodically subject to reviews and audits by various
governmental agencies, particularly in new markets, where the Company has
experienced high rates of growth. Recently, the South Korean Ministry of Trade,
Industry and Energy commenced an examination of the largest foreign and domestic
owned network marketing companies in South Korea, including Nu Skin Korea. The
purposes of the examination were stated to be to monitor how companies are
operating and to audit current business practices. In addition, Nu Skin Korea
has been subject to an audit by the South Korean Customs Service. Management
believes that this audit was precipitated largely as a result of Nu Skin Korea's
rapid growth and its position as the largest importer of cosmetics and personal
care products in South Korea as well as by recent South Korean trade imbalances.
The Customs Service reviewed a broad range of issues relating to the operations
of Nu Skin Korea, with a focus on reviewing customs valuation issues and
intercompany payments. Recently, the Customs Service has resolved certain issues
related to its audit without imposing sanctions. The intercompany payment issue
was referred to various other government agencies which have also recently
concluded their reviews and found no wrong-doing and imposed no fines, sanctions
or other restrictions. The import valuation issues, which management considers
to be routine in light of the Company's extensive import and export activities,
were referred to the valuation division of the Customs Service. The Company
continues to believe that its actions have been in compliance in all material
respects with relevant regulations. See "--Potential Negative Impact of
Distributor Actions." Management believes that other major importers of cosmetic
products are also the focus of regulatory reviews by South Korean authorities.
Businesses which are more than 50% owned by non-citizens are not permitted
to operate in Thailand unless they have an Alien Business Permit, which is
frequently difficult to obtain. The Company is currently operating under the
Treaty of Amity and Economic Relations between Thailand and the United States
(the "Treaty of Amity"). Under the Treaty of Amity, an Alien Business Permit is
not required if a Thailand business is owned by an entity organized in the
United States, a majority of whose owners are U.S. citizens or entities. From
time to time, it has been reported that certain Thailand government officials
have considered supporting the termination of the Treaty of Amity. There can be
no assurance that, if the Treaty of Amity were terminated, the Company would be
able to obtain an Alien Business Permit and continue operations in Thailand.
Based on the Company's and NSI's experience and research (including
assistance from counsel) and the nature and scope of inquiries from government
regulatory authorities, the Company believes that it is in material compliance
with all regulations applicable to the Company. Despite this belief, either the
Company or NSI could be found not to be in material compliance with existing
regulations as a result of, among other things, the considerable interpretative
and enforcement discretion given to regulators or misconduct by independent
distributors. In 1994, NSI and three of its distributors entered into a consent
decree with the United States Federal Trade Commission (the "FTC") with respect
to its investigation of certain product claims and distributor practices,
pursuant to which NSI paid approximately $1 million to settle the FTC
investigation. In August 1997, NSI reached a settlement with the FTC with
respect to certain product claims and its compliance with the 1994 consent
decree pursuant to which settlement NSI paid $1.5 million to the FTC. In
connection with the August 1997 settlement, NSI also voluntarily agreed to
recall and rewrite virtually all of its sales and marketing materials to address
FTC concerns. In February 1998, the State of Pennsylvania filed a lawsuit
against NSI and one of its affiliates Big Planet, Inc. ("Big Planet"), alleging
violations of Pennsylvania law. In early March 1998, NSI and Big Planet agreed
to suspend for 30 days all sales and recruitment efforts related to Big Planet's
potential electricity marketing program. Big Planet also volunteered certain
other restrictions on its business. NSI's primary business of distributing
personal care and nutritional products was unaffected by the lawsuit. These
events were reported in certain media.
Even though neither the Company nor the Subsidiaries has encountered
similar regulatory concerns, there can be no assurances that the Company and the
Subsidiaries will not be subject to similar inquiries and regulatory
investigations or disputes and the effects of any adverse publicity resulting
therefrom. Any assertion or determination that either the Company, NSI or any
NSI distributors are not in compliance with existing laws or regulations could
potentially have a material adverse effect on the Company's business and results
of operations. In addition, in any country or jurisdiction, the adoption of new
laws or regulations or changes in the interpretation
13
of existing laws or regulations could generate negative publicity and/or have a
material adverse effect on the Company's business and results of operations. The
Company cannot determine the effect, if any, that future governmental
regulations or administrative orders may have on the Company's business and
results of operations. Moreover, governmental regulations in countries where the
Company plans to commence or expand operations may prevent, delay or limit
market entry of certain products or require the reformulation of such products.
Regulatory action, whether or not it results in a final determination adverse to
the Company or NSI, has the potential to create negative publicity, with
detrimental effects on the motivation and recruitment of distributors and,
consequently, on the Company's sales and earnings. See "--Potential Effects of
Adverse Publicity" and "--Entering New Markets."
Reliance on Certain Distributors; Potential Divergence of Interests between
Distributors and the Company
The Global Compensation Plan allows distributors to sponsor new
distributors. The sponsoring of new distributors creates multiple distributor
levels in the network marketing structure. Sponsored distributors are referred
to as "downline" distributors within the sponsoring distributor's "downline
network." If downline distributors also sponsor new distributors, additional
levels of downline distributors are created, with the new downline distributors
also becoming part of the original sponsor's "downline network." As a result of
this network marketing distribution system, distributors develop relationships
with other distributors, both within their own countries and internationally.
The Company believes that its revenue is generated from thousands of distributor
networks. However, the Company estimates that, as of December 31, 1997,
approximately 300 distributorships worldwide comprised NSI's two highest
executive distributor levels (Hawaiian Blue Diamond and Blue Diamond
distributors). These distributorships have developed extensive downline networks
which consist of thousands of sub-networks. Together with such networks, these
distributorships account for substantially all of the Company's revenue.
Consequently, the loss of such a high-level distributor or another key
distributor together with a group of leading distributors in such distributor's
downline network, or the loss of a significant number of distributors for any
reason, could adversely affect sales of the Company's products, impair the
Company's ability to attract new distributors and adversely impact earnings.
Under the Global Compensation Plan, a distributor receives commissions
based on products sold by the distributor and by participants in the
distributor's worldwide downline network, regardless of the country in which
such participants are located. The Company, on the other hand, receives revenues
based almost exclusively on sales of products to distributors within the
Company's markets. So, for example, if a distributor located in Japan sponsors a
distributor in Europe, the Japanese distributor could receive commissions based
on the sales made by the European distributor, but the Company would not receive
any revenue since the products would have been sold outside of the Company's
markets. The interests of the Company and distributors therefore diverge
somewhat in that the Company's primary objective is to maximize the amount of
products sold within the Company's markets, while the distributors' objective is
to maximize the amount of products sold by the participants in the distributors'
worldwide downline networks. The Company and NSI have observed that the
commencement of operations in a new country tends to distract the attention of
distributors from the established markets for a period of time while key
distributors begin to build their downline networks within the new country. NSI
is currently contemplating opening operations in additional countries outside of
the Company's markets. To the extent distributors focus their energies on
establishing downline networks in these new countries, and decrease their focus
on building organizations within the Company's markets, the Company's business
and results of operations could be adversely affected. Furthermore, the Company
itself is currently contemplating opening new markets. In the event distributors
focus on these new markets, sales in existing markets might be adversely
affected. There can be no assurance that these new markets will develop or that
any increase in sales in new markets will not be more than offset by a decrease
in sales in the Company's existing markets.
Entering New Markets
As part of its growth strategy, the Company has acquired from NSI the
right to act as NSI's exclusive distribution vehicle in Indonesia, Malaysia, the
PRC, Singapore and Vietnam. The Company has undertaken
14
reviews of the laws and regulations to which its operations would be subject in
Indonesia, Malaysia, the PRC, Singapore and Vietnam. Given existing regulatory
environments and economic conditions, the Company's entrance into Singapore and
Vietnam is not anticipated in the short to mid-term. The regulatory and
political climate in the other countries for which the Company has the right to
act as NSI's exclusive distributor is such that a replication of the Company's
current operating structure cannot be guaranteed. Because the Company's personal
care and nutritional product lines are positioned as premium product lines, the
market potential for the Company's product lines in relatively less developed
countries, such as the PRC and Vietnam, remains to be determined. Modifications
to each product line may be needed to accommodate the market conditions in each
country, while maintaining the integrity of the Company's products. No assurance
can be given that the Company will be able to obtain necessary regulatory
approvals to commence operations in these new markets, or that, once such
approvals are obtained, the Company and NSI, upon which the Company is largely
dependent for product development assistance, will be able to successfully
reformulate Nu Skin personal care and IDN product lines in any of the Company's
new markets to attract local consumers.
Each of the proposed new markets will present additional unique
difficulties and challenges. The PRC, for example, has proven to be a
particularly difficult market for foreign corporations due to its extensive
government regulation and historical political tenets, and no assurance can be
given that the Company will be able to establish Nu Skin operations in the PRC
using the Company's business model or otherwise. The Company believes that
entering the PRC may require the successful establishment of a joint venture
enterprise with a Chinese partner and the establishment of a local manufacturing
presence. These initiatives would likely require a significant investment over
time by the Company. The Company believes that the PRC national regulatory
agency responsible for direct selling periodically reviews the regulation of
multi-level marketing. Management is aware of recent media and other reports in
the PRC reporting an increasing desire on the part of senior government officers
to curtail or even abolish direct selling and multi-level marketing activities.
These views may lead to changes in applicable regulations. The Company believes
that PRC regulators are currently not issuing direct selling or multi-level
marketing licenses and may take action restricting or rescinding currently
licensed direct selling businesses. The Company is actively working on these and
other issues including joint ventures and potential marketing alternatives
related to possible Nu Skin operations in the PRC. It is not known when or
whether the Company will be able to implement in the PRC business models
consistent with those used by the Company in other markets. The Company will
likely have to apply for licenses on a province by province basis, and the
repatriation of the Company's profits will be subject to restrictions on
currency conversion and the fluctuations of the government controlled exchange
rate. In addition, because distribution systems in the PRC are greatly
fragmented, the Company may be forced to use business models significantly
different from those used by the Company in more developed countries. The lack
of a comprehensive legal system, the uncertainties of enforcement of existing
legislation and laws, and potential revisions of existing laws could have an
adverse effect on the Company's proposed business in the PRC.
The other potential new markets also present significant regulatory,
political and economic obstacles to the Company. In Singapore, for example,
network marketing is currently illegal and is not permitted under any
circumstances. Although the Company believes that this restriction will
eventually be relaxed or repealed, no assurance can be given that such
regulation will not remain in place and that the Company will not be permanently
prevented from initiating sales in Singapore. In addition, Malaysia has
governmental guidelines that have the effect of limiting foreign ownership of
direct selling companies operating in Malaysia to no more than 30%. There can be
no assurance that the Company will be able to properly structure Malaysian
operations to comply with this policy. In October of 1995, the Company's
business permit applications were denied by the Malaysian government as a result
of activities by certain NSI distributors. Therefore, the Company believes that
although significant opportunities exist to expand its operations into new
markets, there can be no assurance that these or other difficulties will not
prevent the Company from realizing the benefits of this opportunity.
15
Managing Growth
The Company has experienced rapid growth since operations in Hong Kong
commenced in 1991. The management challenges imposed by this growth include
entry into new markets, growth in the number of employees and distributors,
expansion of facilities necessary to accommodate growth and additions and
modifications to the Company's product lines. To manage these changes
effectively, the Company may be required to hire additional management and
operations personnel and to improve its operational, financial and management
systems.
Possible Adverse Effect on the Company of the Change in the Status of Hong Kong
The Company has offices and a portion of its operations in Hong Kong.
Effective July 1, 1997, the exercise of sovereignty over Hong Kong was
transferred from the Government of the United Kingdom of Great Britain and
Northern Ireland (the "United Kingdom"), to the government of the PRC pursuant
to the Sino-British Joint Declaration on the Question of Hong Kong (the "Joint
Declaration"), and Hong Kong became a Special Administrative Region ("SAR") of
the PRC. The Joint Declaration provided for Hong Kong to be under the authority
of the government of the PRC but Hong Kong will enjoy a high degree of autonomy
except in foreign and defense affairs, and that Hong Kong be vested with
executive, legislative and independent judicial power. The Joint Declaration
also provides that the current social and economic systems in Hong Kong will
remain unchanged for 50 years after June 30, 1997 and that Hong Kong will retain
the status of an international financial center. Although sales in Hong Kong
accounted for less than 5% of the Company's revenues for the year ended December
31, 1997, Hong Kong serves as the location for the Company's regional offices
and an important base of operations for many of the Company's most successful
distributors whose downline distributor networks extend into other Asian
markets. Any adverse effect on the social, political or economic systems in Hong
Kong resulting from this transfer could have a material adverse effect on the
Company's business and results of operations. Although the Company does not
anticipate any material adverse change in the business environment in Hong Kong
resulting from the 1997 transfer of sovereignty, the Company has formulated
contingency plans to transfer the Company's regional office to another
jurisdiction in the event that the Hong Kong business environment is so
affected.
Relationship with and Reliance on NSI; Potential Conflicts of Interest
NSI has ownership and control of the NSI trademarks, tradenames, the
Global Compensation Plan, the Licensed Property and licenses to the Company
rights to use the Licensed Property in certain markets. NSI and its affiliates
currently operate in 17 countries, excluding the countries in which the Company
currently operates, and will continue to market and sell Nu Skin personal care
and IDN nutritional products in these countries, as well as in additional
countries outside of the Company's markets, through the network marketing
channel. Thus, the Company cannot use the NSI trademarks to expand into other
markets for which the Company does not currently have a license without first
obtaining additional licenses or other rights from NSI. There can be no
assurance that NSI will make any additional markets available to the Company or
that the terms of any new licenses from NSI will be acceptable to the Company.
See "Recent Developments."
NSI has licensed to the Company, through the Subsidiaries, rights to
distribute Nu Skin and IDN products and to use the Licensed Property in the
Company's markets, and NSIMG, an affiliate of NSI, will provide management
support services to the Company and the Subsidiaries, pursuant to distribution,
trademark/tradename license, licensing and sales, and management services
agreements (the "Operating Agreements"). The Company relies on NSI for research,
development, testing, labeling and regulatory compliance for products sold to
the Company under the distribution agreements, and virtually all of the
Company's revenues are derived from products and sales aids purchased from NSI
pursuant to these agreements. NSIMG provides the Company with a variety of
management and consulting services, including, but not limited to, management,
legal, financial, marketing and distributor support/training, public relations,
international expansion, human resources, strategic planning, product
development and operations administration services. Each of the Operating
Agreements (other than the distribution,
16
trademark/tradename license and licensing and sales agreements for Nu Skin
Korea, which have shorter terms), is for a term ending December 31, 2016, and is
subject to renegotiation after December 31, 2001, in the event that the Original
Stockholders and their affiliates, on a combined basis, no longer beneficially
own a majority of the combined voting power of the outstanding shares of Common
Stock of the Company or of the common stock of NSI. The Company is almost
completely dependent on the Operating Agreements to conduct its business, and in
the event NSI is unable or unwilling to perform its obligations under the
Operating Agreements, or terminates the Operating Agreements as provided
therein, the Company's business and results of operations will be adversely
affected. See "Recent Developments."
After consummation of the NSI Acquisition, approximately 98% of the
combined voting power of the outstanding shares of Common Stock will be held by
the Original Stockholders and certain of their affiliates. Consequently, the
Original Stockholders and certain of their affiliates will have the ability,
acting in concert, to elect all directors of the Company and approve any action
requiring approval by a majority of the stockholders of the Company. Certain of
the Original Stockholders also own 100% of the outstanding shares of NSI. As a
result of this ownership, and if the NSI Acquisition is not consummated, the
Original Stockholders who are also shareholders of NSI will consider the
short-term and the long-term impact of all stockholder decisions on the
consolidated financial results of NSI and the Company. See "--Control by
Original Stockholders; Anti-Takeover Effects of Dual Classes of Common Stock."
The Operating Agreements were approved by the Board of Directors of the
Company, which was, except with respect to the approval of the Operating
Agreements with Nu Skin Thailand, composed entirely of individuals who were also
officers and shareholders of NSI at the time of approval. The Operating
Agreements with Nu Skin Thailand and Nu Skin Philippines were approved by a
majority of the disinterested directors of the Company. In addition, some of the
executive officers of the Company are also executive officers of NSI. It is
expected that a number of the Company's executive officers will continue to
spend a portion of their time on the affairs of NSI, for which they will
continue to receive compensation from NSI.
In view of the substantial relationships between the Company and NSI,
conflicts of interest may exist or arise with respect to existing and future
business dealings, including, without limitation, the relative commitment of
time and energy by the executive officers to the respective businesses of the
Company and NSI, potential acquisitions of businesses or properties, the
issuance of additional securities, the election of new or additional directors
and the payment of dividends by the Company. There can be no assurance that any
conflicts of interest will be resolved in favor of the Company. Under Delaware
and Utah law, a person who is a director of both the Company and NSI owes
fiduciary duties to both corporations and their respective shareholders. As a
result, persons who are directors of both the Company and NSI are required to
exercise their fiduciary duties in light of what they believe to be best for
each of the companies and its shareholders.
Control by Original Stockholders; Anti-Takeover Effect of Dual Classes of Common
Stock
Because of the relationship between the Company and NSI, management
elected to structure the capitalization of the Company in such a manner as to
minimize the possibility of a change in control of the Company without the
consent of the Original Stockholders. Consequently, the shares of Class B Common
Stock enjoy ten to one voting privileges over the shares of Class A Common Stock
until the outstanding shares of Class B Common Stock constitute less than 10% of
the total outstanding shares of Common Stock. After consummation of the
Offerings, and the NSI Acquisition, the Original Stockholders and certain of
their affiliates will collectively own 100% of the outstanding shares of the
Class B Common Stock, representing approximately 98% of the combined voting
power of the outstanding shares of Common Stock. Accordingly, the Original
Stockholders and certain of their affiliates, acting fully or partially in
concert, will have the ability to control the election of the Board of Directors
of the Company and thus the direction and future operations of the Company
without the supporting vote of any other stockholder of the Company, including
decisions regarding acquisitions and other business opportunities, the
declaration of dividends and the issuance of additional shares of Class A Common
Stock and other securities. NSI is a privately-held company, all of the shares
of which are owned prior to consummation
17
of the NSI Acquisition by certain of the Original Stockholders. As long as the
shareholders of NSI prior to consummation of the NSI Acquisition are majority
stockholders of the Company, assuming they act in concert, third parties will
not be able to obtain control of the Company through purchases of shares of
Class A Common Stock. See "Description of Capital Stock."
Adverse Impact on Company Income Due to Distributor Option Program
Prior to the Underwritten Offerings, the Original Stockholders converted
1,605,000 shares of Class B Common Stock to Class A Common Stock and contributed
such shares of Class A Common Stock to the Company. The Company granted to NSI
options to purchase such shares of Class A Common Stock (the "Distributor
Options"), and NSI offered these options to qualifying distributors of NSI. The
Exercise Price for each Distributor Option is $5.75, which is 25% of the initial
price per share to the public of the Class A Common Stock in the Underwritten
Offerings. The Distributor Options vested December 31,1997. The shares of Class
A Common Stock underlying the Distributor Options have been registered pursuant
to Rule 415 under the 1933 Act.
The Company incurred a total pre-tax non-cash compensation expense of
$19.9 million in connection with the grant of the Distributor Options. This
non-cash compensation expense resulted in a corresponding impact on net income
and net income per share.
Reliance on and Concentration of Outside Manufacturers
Virtually all the Company's products are sourced through NSI and are
produced by manufacturers unaffiliated with NSI. The Company currently has
little or no direct contact with these manufacturers. The Company's profit
margins and its ability to deliver its existing products on a timely basis are
dependent upon the ability of NSI's outside manufacturers to continue to supply
products in a timely and cost-efficient manner. Furthermore, the Company's
ability to enter new markets and sustain satisfactory levels of sales in each
market is dependent in part upon the ability of suitable outside manufacturers
to reformulate existing products, if necessary to comply with local regulations
or market environments, for introduction into such markets. Finally, the
development of additional new products in the future will likewise be dependent
in part on the services of suitable outside manufacturers.
The Company currently acquires products or ingredients from sole suppliers
or suppliers that are considered by the Company to be the superior suppliers of
such ingredients. The Company believes that, in the event it is unable to source
any products or ingredients from its current suppliers, the Company could
produce such products or replace such products or substitute ingredients without
great difficulty or prohibitive increases in the cost of goods sold. However,
there can be no assurance that the loss of such a supplier would not have a
material adverse effect on the Company's business and results of operations.
With respect to sales to the Company, NSI currently relies on two
unaffiliated manufacturers to produce approximately 70% and 80% of its personal
care and nutritional products, respectively. NSI has a written agreement with
the primary supplier of the Company's personal care products that expires at the
end of 2000. An extension to such contract is currently being negotiated. NSI
does not currently have a written contract with the primary supplier of the
Company's nutritional products. The Company believes that in the event that
NSI's relationship with any of its key manufacturers is terminated, NSI will be
able to find suitable replacement manufacturers. However, there can be no
assurance that the loss of either manufacturer would not have a material adverse
effect on the Company's business and results of operations.
Reliance on Operations of and Dividends and Distributions from Subsidiaries
The Company is a holding company without operations of its own or
significant assets other than ownership of 100% of the capital stock of each of
the Subsidiaries. Accordingly, an important source of the Company's income will
be dividends and other distributions from the Subsidiaries. Each of the
Subsidiaries has
18
its operations in a country other than the United States, the country in which
the Company is organized. In addition, each of the Subsidiaries receives its
revenues in the local currency of the country or jurisdiction in which it is
situated. As a consequence, the Company's ability to obtain dividends or other
distributions is subject to, among other things, restrictions on dividends under
applicable local laws and regulations, and foreign currency exchange regulations
of the country or jurisdictions in which the Subsidiaries operate. The
Subsidiaries' ability to pay dividends or make other distributions to the
Company is also subject to their having sufficient funds from their operations
legally available for the payment of such dividends or distributions that are
not needed to fund their operations, obligations or other business plans.
Because the Company will be a stockholder of each of the Subsidiaries, the
Company's claims as such will generally rank junior to all other creditors of
and claims against the Subsidiaries. In the event of a Subsidiary's liquidation,
there may not be assets sufficient for the Company to recoup its investment in
such Subsidiary.
Taxation Risks and Transfer Pricing
The Company is subject to taxation in the United States, where it is
incorporated, at a statutory corporate federal tax rate of 35.0% plus any
applicable state income taxes. In addition, each Subsidiary is subject to
taxation in the country in which it operates, currently ranging from a statutory
tax rate of 57.9% in Japan to 16.5% in Hong Kong. The Company is eligible to
receive foreign tax credits in the U.S. for the amount of foreign taxes actually
paid in a given period. In the event that the Company's operations in high tax
jurisdictions such as Japan grow disproportionately to the rest of the Company's
operations, the Company will be unable to fully utilize its foreign tax credits
in the U.S., which could, accordingly, result in the Company paying a higher
overall effective tax rate on its worldwide operations.
Because the Subsidiaries operate outside of the United States, the Company
is subject to the jurisdiction of numerous foreign tax authorities. In addition
to closely monitoring the Subsidiaries' locally based income, these tax
authorities regulate and restrict various corporate transactions, including
intercompany transfers. The Company believes that the tax authorities in Japan
and South Korea are particularly active in challenging the tax structures of
foreign corporations and their intercompany transfers. The Company is currently
undergoing a customs audit in South Korea. See "--Government Regulation of
Products and Marketing; Import Restrictions" and "--Other Regulatory Issues."
Although the Company believes that its tax and transfer pricing structures are
in compliance in all material respects with the laws of every jurisdiction in
which it operates, no assurance can be given that these structures will not be
challenged by foreign tax authorities or that such challenges or any required
changes in such structures will not have a material adverse effect on the
Company's business or results of operations.
Increase in Distributor Compensation Expense
Under the Licensing and Sales Agreements (the "Licensing and Sales
Agreements") between each of the Subsidiaries and NSI, the Company, through its
Subsidiaries, is contractually obligated to pay a distributor commission expense
of 42% of commissionable product sales (with the exception of South Korea where,
due to government regulations, the Company uses a formula based upon a maximum
payout of 35% of commissionable product sales). The Licensing and Sales
Agreements provide that the Company is to satisfy this obligation by paying
commissions owed to local distributors. In the event that these commissions
exceed 42% of commissionable product sales, the Company is entitled to receive
the difference from NSI. In the event that the commissions paid are lower than
42%, the Company must pay the difference to NSI. Under this formulation, the
Company's total commission expense is fixed at 42% of commissionable product
sales in each country (except for South Korea). The 42% figure has been set on
the basis of NSI's experience over the past eight years during which period
actual commissions paid in a given year together with the cost of administering
the Global Compensation Plan have ranged between 41% and 43% of commissionable
product sales for such year (averaging approximately 42%). In the event that
actual commissions payable to distributors from sales in the Company's markets
vary from these historical results, whether as a result of changes in
distributor behavior or changes to the Global Compensation Plan or in the event
that NSI's cost of administering the Global Compensation Plan increases
19
or decreases, the Licensing and Sales Agreements provide that the intercompany
settlement figure may be modified to more accurately reflect actual results.
This could result in the Company becoming obligated to make greater settlement
payments to NSI under the Licensing and Sales Agreements. Such additional
payments could adversely affect the Company's results of operations. Because the
Company licenses the right to use the Global Compensation Plan from NSI, the
structure of the plan, including commission rates, is under the control of NSI.
Product Liability
The Company may be subject, under applicable laws and regulations, to
liability for loss or injury caused by its products. The Company's Subsidiaries
are currently covered for product liability claims to the extent of and under
insurance programs maintained by NSI for their benefit and for the benefit of
its affiliates purchasing NSI products. Accordingly, NSI maintains a policy
covering product liability claims for itself and its affiliates with a $1
million per claim and $1 million annual aggregate limit and an umbrella policy
with a $40 million per claim and $40 million annual aggregate limit. Although
the Company has not been the subject of material product liability claims and
the laws and regulations providing for such liability in the Company's markets
appear to have been seldom utilized, no assurance can be given that the Company
may not be exposed to future product liability claims, and, if any such claims
are successful, there can be no assurance that the Company will be adequately
covered by insurance or have sufficient resources to pay such claims. The
Company does not currently maintain its own product liability policy.
Competition
The markets for personal care and nutritional products are large and
intensely competitive. The Company competes directly with companies that
manufacture and market personal care and nutritional products in each of the
Company's product lines. The Company competes with other companies in the
personal care and nutritional products industry by emphasizing the value and
premium quality of the Company's products and the convenience of the Company's
distribution system. Many of the Company's competitors have much greater name
recognition and financial resources than the Company. In addition, personal care
and nutritional products can be purchased in a wide variety of channels of
distribution. While the Company believes that consumers appreciate the
convenience of ordering products from home through a sales person or through a
catalog, the buying habits of many consumers accustomed to purchasing products
through traditional retail channels are difficult to change. The Company's
product offerings in each product category are also relatively small compared to
the wide variety of products offered by many other personal care and nutritional
product companies. There can be no assurance that the Company's business and
results of operations will not be affected materially by market conditions and
competition in the future.
The Company also competes with other direct selling organizations, some of
which have longer operating histories and higher visibility, name recognition
and financial resources. The leading network marketing company in the Company's
existing markets is Amway Corporation and its affiliates. The Company competes
for new distributors on the basis of the Global Compensation Plan and its
premium quality products. Management envisions the entry of many more direct
selling organizations into the marketplace as this channel of distribution
expands over the next several years. The Company has been advised that certain
large, well-financed corporations are planning to launch direct selling
enterprises which will compete with the Company in certain of its product lines.
There can be no assurance that the Company will be able to successfully meet the
challenges posed by this increased competition.
The Company competes for the time, attention and commitment of its
independent distributor force. Given that the pool of individuals interested in
the business opportunities presented by direct selling tends to be limited in
each market, the potential pool of distributors for the Company's products is
reduced to the extent other network marketing companies successfully recruit
these individuals into their businesses. Although management believes that the
Company offers an attractive business opportunity, there can be no assurance
that other network marketing
20
companies will not be able to recruit the Company's existing distributors or
deplete the pool of potential distributors in a given market.
Operations Outside the United States
The Company's revenues and most of its expenses are recognized primarily
outside of the United States. Therefore, the Company is subject to transfer
pricing regulations and foreign exchange control, taxation, customs and other
laws. The Company's operations may be materially and adversely affected by
economic, political and social conditions in the countries in which it operates.
A change in policies by any government in the Company's markets could adversely
affect the Company and its operations through, among other things, changes in
laws, rules or regulations, or the interpretation thereof, confiscatory
taxation, restrictions on currency conversion, currency repatriation or imports,
or the expropriation of private enterprises. Although the general trend in these
countries has been toward more open markets and trade policies and the fostering
of private business and economic activity, no assurance can be given that the
governments in these countries will continue to pursue such policies or that
such policies will not be significantly altered in future periods. This could be
especially true in the event of a change in leadership, social or political
disruption or upheaval, or unforeseen circumstances affecting economic,
political or social conditions or policies. The Company is aware of news
releases in South Korea, for example, reporting comments by political figures
proposing restrictions on foreign direct sellers designed to protect the market
share of local companies. There can be no assurance that such activities, or
other similar activities in the Company's markets, will not result in passage of
legislation or the enactment of policies which could materially adversely affect
the Company's operations in these markets. In addition, the Company's ability to
expand its operations into the new markets for which it has received an
exclusive license to distribute NSI products will directly depend on its ability
to secure the requisite government approvals and comply with the local
government regulations in each of those countries. The Company has in the past
experienced difficulties in obtaining such approvals as a result of certain
actions taken by its distributors, and no assurance can be given that these or
similar problems will not prevent the Company from commencing operations in
those countries. See "--Entering New Markets."
Anti-Takeover Effects of Certain Charter, Contractual and Statutory Provisions
The Board of Directors is authorized, subject to certain limitations, to
issue without further consent of the stockholders up to 25,000,000 shares of
preferred stock with rights, preferences and privileges designated by the Board
of Directors. In addition, the Company's Certificate of Incorporation requires
the approval of 662/3% of the outstanding voting power of the Class A Common
Stock and the Class B Common Stock to authorize or approve certain change of
control transactions. See "Description of Capital Stock--Common Stock--Voting
Rights" and "--Mergers and Other Business Combinations." The Company's
Certificate of Incorporation and Bylaws also contain certain provisions that
limit the ability to call special meetings of stockholders and the ability of
stockholders to bring business before or to nominate directors at a meeting of
stockholders. See "Description of Capital Stock--Other Charter and Bylaw
Provisions." Pursuant to the 1996 Stock Incentive Plan, in the event of certain
change of control transactions the Board of Directors has the right, under
certain circumstances, to accelerate the vesting of options and the expiration
of any restriction periods on stock awards. Finally, the Operating Agreements
with NSI and NSIMG are subject to renegotiation after December 31, 2001 upon a
change of control of the Company. Any of these actions, provisions or
requirements could have the effect of delaying, deferring or preventing a change
of control of the Company. See "Recent Developments."
The Company is subject to the provisions of Section 203 of the General
Corporation Law of the State of Delaware (the "Anti-Takeover Law") regulating
corporate takeovers. The Anti-Takeover Law prevents certain Delaware
corporations, including those whose securities are listed on the New York Stock
Exchange, from engaging, under certain circumstances, in a "business
combination" (which includes a merger of more than 10% of the corporations'
assets) with an "interested stockholder" (a stockholder who, together with
affiliates and associates, within the prior three years owned 15% or more of the
corporation's outstanding voting stock) for three years following the date that
such stockholder became an "interested stockholder," unless the "business
combination" or "interested stockholder" is approved in a prescribed manner. A
Delaware corporation may "opt
21
out" of the Anti-Takeover Law with an express provision in its original
certificate of incorporation or an express provision in its certificate of
incorporation or bylaws resulting from a stockholders' amendment approved by at
least a majority of the outstanding voting shares. The Company has not "opted
out" of the provisions of the Anti-Takeover Law.
Restrictions on Resale of Shares Underlying Distributor Options
By exercising any portion of his or her Distributor Options, each
distributor who has been granted more than 3,000 Distributor Options will agree
not to resell in any given six-month period more than 33% of the shares of Class
A Common Stock issuable upon exercise of the Distributor Options held by such
distributor. See "Plan of Distribution--Distributor Options."
Regulatory and Taxation Risks
The availability of employee stock bonus awards in each country in which
NSI distributors and/or employees reside is entirely dependent upon and subject
to NSI's ability to secure any necessary regulatory approvals, qualifications or
exemptions in each such country. There can be no assurance that such approvals
or qualifications will be secured or, once secured, will not be suspended. It is
possible that NSI may not be able to secure the necessary regulatory approvals
or qualifications in certain countries. The receipt of employee stock bonus
awards will also subject the recipient to potentially material income tax
implications. The Company and its affiliates anticipate that the shares of Class
A Common Stock underlying the employee stock bonus awards will be qualified in
some form pursuant to the securities laws of each jurisdiction in which the
Company and its affiliates operate. There can be no assurance, however, that NSI
will be able to qualify the employee stock bonus awards in each jurisdiction or
that, if qualified, the governmental authorities in such jurisdictions will not
require material modifications to the terms of the programs as they are
currently contemplated to be implemented. In addition, there can be no assurance
that the laws and relevant regulations and judicial and administrative
interpretations in such jurisdictions will not change in a manner that has a
material impact on the ability of NSI to adopt or maintain such programs in such
jurisdictions. The NSI Distributor Stock Option Plan, as amended (the "NSI
Distributor Stock Option Plan"), as it is implemented or administered in any
given country where distributors of NSI reside or act as independent
distributors of NSI, may be amended or modified by NSI's board of directors from
time to time to comply with the legal requirements and restrictions of such
country. See "Plan of Distribution --Regulatory and Tax Issues."
Absence of Dividends
The Company does not anticipate that any dividends will be declared on
either its Class A Common Stock or its Class B Common Stock in the immediate
future. The Company intends from time to time to re-evaluate this policy based
on its net income and its alternative uses for retained earnings, if any. Any
future declaration of dividends will be subject to the discretion of the board
of directors of the Company (the "Board of Directors") and subject to certain
limitations under the General Corporation Law of the State of Delaware (the
"DGCL"). The timing, amount and form of dividends, if any, will depend, among
other things, on the Company's results of operations, financial condition, cash
requirements and other factors deemed relevant by the Board of Directors. See
"--Reliance on Operations of and Dividends and Distributions from Subsidiaries."
Shares Eligible For Future Sale
Future sales of substantial amounts of the Class A Common Stock in the
public market or the perception that such sales could occur may have an adverse
effect on the market price of the Class A Common Stock. In addition, any future
issuances of Class A Common Stock or other capital stock of the Company could
also be dilutive to investors in the Class A Common Stock. See "Recent
Developments" and "Description of Capital Stock--Preferred Stock--The NSI
Acquisition." As of March 5, 1998, 11,835,737 shares of Class A Common Stock
were outstanding. All of the outstanding shares of Class A Common Stock are
freely tradeable without
22
restriction or further registration under the Securities Act, unless held by
"affiliates" of the Company, as that term is defined in Rule 144 of the
Securities Act ("Rule 144"). The shares of Class A Common Stock underlying the
Distributor Options and the employee stock bonus awards to be issued pursuant to
the Rule 415 Offerings are subject to certain vesting and resale limitations.
In addition to the shares to be issued pursuant to the Rule 415 Offerings,
an aggregate of approximately 3,825,000 shares have been reserved for issuance
for future option grants and other equity awards under the NSAP 1996 Stock
Incentive Plan. The Company intends to file a registration statement on Form S-8
under the Securities Act to register all of the shares of Class A Common Stock
reserved for issuance under the NSAP 1996 Stock Incentive Plan. In addition, the
Company has reserved 250,825 shares of Class A Common Stock to be issued upon
the exercise of a stock option granted to an executive officer of the Company.
As of March 5, 1998, the number of outstanding shares of Class B Common
Stock was 70,280,759, each share of which is convertible at any time into one
share of Class A Common Stock. All shares of the Class B Common Stock are
"restricted" shares within the meaning of Rule 144 of the Securities Act.
Restricted shares may not be resold in the public market except in compliance
with the registration requirements of the Securities Act or pursuant to an
exemption therefrom, including the exemption provided by Rule 144. The Original
Stockholders have entered into a stockholders agreement (the "Stockholders
Agreement") pursuant to which they agreed not to transfer any shares they own
through November 28, 1998 (the "Initial Lock-up Period") without the consent of
the Company. However, if the NSI Acquisition is consummated, the lock-up period
will automatically be extended until one year following the closing date of the
NSI Acquisition (the "Extended Lock-up Period"). In addition, the Stockholders
Agreement further restricts the number of shares of Class A Common Stock that
may be sold by the Original Stockholders in a public resale pursuant to Rule 144
or any other exempt transaction under the Securities Act for one year following
the last to expire of the Initial Lock-up Period or the Extended Lock-up Period.
The Original Stockholders have been granted registration rights by the Company
permitting each such Original Stockholder to register his or her shares of Class
A Common Stock, subject to certain restrictions, on any registration statement
filed by the Company until such Original Stockholder has sold a specified value
of shares of Class A Common Stock.
USE OF PROCEEDS
Other than the exercise price of such Distributor Options as may be
exercised, the Company will not receive any proceeds from the distribution of
shares of Class A Common Stock by the Company and the Rule 415 Selling
Stockholders in connection with the employee stock bonus awards. The gross
proceeds from the issuance of shares of Class A Common Stock by the Company in
connection with the exercise of the Distributor Options are estimated to be
approximately $9.2 million (assuming the exercise of all 1,605,000 Distributor
Options). Any proceeds received by the Company will be used for general
corporate purposes, which may include additional capital expansion projects.
Pending such use, the Company intends to invest such proceeds, if any, in
short-term, interest bearing, investment grade instruments.
RULE 415 SELLING STOCKHOLDERS
Prior to the date of this Prospectus, the Original Stockholders
contributed an aggregate of 1,250,000 shares of Class A Common Stock to NSI and
its affiliates (other than the Company) for use in connection with the employee
stock bonus awards to be made by the Rule 415 Selling Stockholders to their
respective employees pursuant to their respective stock incentive plans in
connection with the Rule 415 Offerings. See "Plan of Distribution." The
following table sets forth the name of each Rule 415 Selling Stockholder for
whom shares of
23
Class A Common Stock have been registered pursuant to Rule 415 under the
Securities Act, the number of shares of Class A Common Stock owned and to be
offered in Rule 415 Offerings by each Rule 415 Selling Stockholder and the total
voting power of each Rule 415 Selling Stockholder after the Rule 415 Offerings.
Class A Common Stock
--------------------------------------------------
Owned and To Be Offered in To Be Owned After the
the Rule 415 Offerings(2) Rule 415 Offering
-------------------------- ---------------------
Rule 415 Selling Stockholders(1) Number Number %
-------------------------------- ---------- -------- ---
Nu Skin International, Inc. .............. 1,136,524 -- --
Nu Skin Personal Care Australia, Inc. .... 25,148 -- --
Nu Skin New Zealand, Inc. ................ 5,110 -- --
Nu Skin Mexico, Inc. ..................... 13,483 -- --
Nu Skin Guatemala, Inc. .................. 1,500 -- --
Nu Skin Canada, Inc. ..................... 33,775 -- --
Nu Skin Netherlands, Inc. ................ 3,398 -- --
Nu Skin U.K., Inc. ....................... 5,755 -- --
Nu Skin Germany, Inc. .................... 4,236 -- --
Nu Skin Belgium, Inc. .................... 3,400 -- --
Nu Skin France, Inc. ..................... 6,193 -- --
Nu Skin Italy, Inc. ...................... 4,157 -- --
Nu Skin Spain, Inc. ...................... 4,894 -- --
Nu Skin Puerto Rico, Inc. ................ 2,427 -- --
- -----------
(1) Each of the Rule 415 Selling Stockholders is an affiliate of the Company
in that each Rule 415 Selling Stockholder is owned by the same individuals
who owned approximately 98% of the voting control of the Common Stock as
of the date of this Prospectus. See "Recent Developments."
(2) Includes up to 1,250,000 shares of Class A Common Stock to be offered by
the Rule 415 Selling Stockholders in connection with employee stock bonus
awards.
In addition to the shares of Class A Common Stock being offered by the
Rule 415 Selling Stockholders, the Company is offering up to 1,605,000 shares of
Class A Common Stock to be issued upon the exercise of Distributor Options and
up to 175,000 shares of Class A Common Stock as employee stock bonus awards to
its employees. See "Plan of Distribution."
PLAN OF DISTRIBUTION
General
This Prospectus may be used from time to time by the holders who offer the
securities registered hereby pursuant to Rule 415 under the Securities Act for
sale in transactions in which they are or may be deemed to be "underwriters"
within the meaning of the Securities Act. The Class A Common Stock may be
offered from time to time directly by the holders or pledgees, donees,
transferees or other successors in interest. Alternatively, the Class A Common
Stock may be offered from time to time by the holders or through brokers or
dealers who may act solely as agents, or may acquire shares as principals. The
distribution of the Class A Common Stock may be effected in one or more
transactions that may take place on the New York Stock Exchange, including block
trades, ordinary brokers' transactions, privately negotiated transactions or
through sales to one or more broker/dealers for resale of such securities as
principals, at market prices prevailing at the time of sale, at prices related
to such prevailing market prices or at negotiated prices. Usual and customary or
specifically negotiated brokerage fees
24
or commissions may be paid by these holders in connection with such sales. In
connection with such sales, the holders and any participating brokers or dealers
may be deemed "underwriters" as such term is defined in the Securities Act. If
required, a prospectus supplement will be distributed setting forth the names of
any participating brokers or dealers, any applicable commissions or discounts
and the net proceeds to the Rule 415 Selling Stockholders from such sale.
The Rule 415 Selling Stockholders will bear all expenses (including
underwriting discounts and selling commissions, state and local transfer taxes,
and fees and expenses of counsel or other advisors to the Rule 415 Selling
Stockholders) in connection with the registration of the offered securities.
Distributor Options
Prior to the date of this Prospectus, the Original Stockholders
contributed to the Company 1,605,000 shares of the Company's Class A Common
Stock for use in implementing the NSI Distributor Stock Option Plan. Also prior
to the date of this Prospectus, the Company granted to NSI an option (the
"Option") to acquire such 1,605,000 shares of Class A Common Stock, which NSI
Option was divisible and assignable by NSI for purposes of granting Distributor
Options pursuant to the NSI Distributor Stock Option Plan.
Pursuant to the terms of the NSI Distributor Option Plan, NSI has granted
1,605,000 Distributor Options to eligible distributors who achieved and
maintained certain sales volume levels ("Executive Pin Levels") during a
qualifying period in 1997. Each Distributor Option entitles the holder to
purchase one share of Class A Common Stock at an exercise price of $5.75 (the
"Exercise Price"), which is 25% of the initial price per share to the public in
the Company's initial public offering of Class A Common Stock. All of the
1,605,000 Distributor Options have vested and are exercisable by each
distributor until December 31, 2001, provided that the distributor maintains an
Executive Pin Level of "Gold" or higher under the terms of the NSI Distributor
Stock Option Plan until the date of exercise. Because of local legal and other
requirements, the NSI Distributor Stock Option Plan as implemented in the
Netherlands and Hong Kong has been changed to provide that vested distributor
options will be exercisable for 90 days following December 31,1997, provided a
Netherlands or Hong Kong distributor holding such Distributor Options maintains
an Executive Pin Level of Gold or higher until the date of exercise. No
Distributor Options will be exercisable after December 31, 2001. By exercising
any portion of the Distributor Options, each distributor granted more than 3,000
Distributor Options agrees not to resell in any given six-month period more than
33% of the shares of Class A Common Stock issuable upon exercise of the
Distributor Options originally granted to such distributor.
By receiving an allocation of Distributor Options, each distributor
confirmed his or her agreement to continue to resell or personally consume at
least 80% of all products purchased by such distributor per month. Product
returns after January 1, 1998 will reduce commission levels and may affect
distributor Executive Pin Levels, consequently impacting the number of
Distributor Options received by a distributor. In the event of product returns
occurring after January 1, 1998 which would have affected distributor Executive
Pin Levels or qualification for or vesting of Distributor Options had such
product returns been made during 1997, NSI reserves the right to use any actions
or remedies available to it under the NSI distributor policies and procedures,
as may be amended from time to time, to recoup the value of the Distributor
Options received by an Eligible Distributor in excess of the value of
Distributor Options which would have been received or vested had such product
returns been made prior to January 1, 1998.
Employee Stock Bonus Awards
Prior to the date of this Prospectus, the Original Stockholders also
contributed an aggregate of 1,250,000 shares of Class A Common Stock to NSI and
its affiliates (other than the Company) for use in connection with the employee
stock bonus awards to be made by NSI and its affiliates (other than the Company)
to their respective employees in connection with the Rule 415 Offerings. The
grant of stock bonus awards and the terms thereof will be governed by the
respective stock incentive plans of NSI and its affiliates (other than the
Company).
25
The shares of Class A Common Stock underlying each such employee stock
bonus award will be issued to the employee recipient at a rate of 25% per year
commencing one year following the date of the award, unless otherwise specified,
provided the employee recipient is still employed by NSI or one of its
affiliates (other than the Company). As of March 5, 1998, NSI and its affiliates
(other than the Company) had made stock bonus awards for 466,563 shares of Class
A Common Stock, of which awards for 20,122 shares had lapsed in connection with
the termination of the employee recipients.
The Company will also issue up to 175,000 shares of Class A Common Stock
in connection with stock bonus awards that may be made to its employees pursuant
to the NSAP 1996 Stock Incentive Plan on terms substantially similar to those
described above in relation to the employee stock bonus awards to be made by NSI
and its affiliates (other than the Company). As of March 5, 1998, the Company
has made stock bonus awards for 175,490 shares of Class A Common Stock, of which
awards for 14,104 shares have lapsed in connection with the employment
termination of certain recipients.
Regulatory and Tax Issues
Certain U.S. Tax Consequences to Recipients of Distributor Options and
Employee Stock Bonus Awards. For purposes of the Internal Revenue Code of 1986
as amended (the "Code"), the Distributor Options will be considered
non-qualified stock options. A recipient (an "Option Recipient") of a
non-qualified stock option recognizes no taxable income when a non-qualified
stock option is granted. Upon exercise of a non-qualified stock option, the
Option Recipient recognizes ordinary income equal to the difference between the
exercise price and the fair market value of the shares on the date of exercise.
The Option Recipient recognizes as capital gain or loss any subsequent profit or
loss recognized on the sale or exchange of any shares disposed of or sold. A
recipient (an "Employee Stock Bonus Award Recipient") of restricted stock or
contingent stock is not required to include the value of such shares in income
until the first time such Employee Stock Bonus Award Recipient's rights in the
shares are transferable or not subject to substantial risk of forfeiture,
whichever occurs earlier. In the case of restricted stock or contingent stock,
the amount of such ordinary income will be equal to the excess of the fair
market value of the shares at the time the income is recognized over the amount
(if any) paid for the shares. Recipients of Distributor Options and employee
stock bonus awards should consult their own tax advisors regarding the U.S. tax
consequences of being awarded a Distributor Option or an employee stock bonus
award. In addition, non-U.S. recipients of Distributor Options and employee
stock bonus awards should consult with their own tax advisors regarding the
application of the tax laws of their respective countries to the Distributor
Options and employee stock bonus awards.
Non-U.S. Regulatory and Tax Considerations. The Company and its affiliates
anticipate that the Distributor Options, the shares of Class A Common Stock
underlying the Distributor Options and the employee stock bonus awards will be
qualified in some form pursuant to the securities and regulatory laws of each
jurisdiction in which the Company and its affiliates operate. There can be no
assurance, however, that NSI will be able to qualify the Distributor Options and
the employee stock bonus awards in each jurisdiction or that, if qualified, the
governmental authorities in such jurisdictions will not suspend such
qualifications or require material modifications to the terms of the programs as
they are currently contemplated to be implemented. In certain countries,
including Belgium, France, Spain and possibly others, only existing distributors
and/or existing executive distributors will be allowed to participate in the NSI
Stock Option Plan. In addition, there can be no assurance that the laws and
relevant regulations and judicial and administrative interpretations in
jurisdictions will not change in a manner that has a material impact on the
ability of NSI to adopt or maintain such programs in such jurisdictions.
The exercise of Distributor Options and the sale of the shares of Class A
Common Stock underlying such Distributor Options, and receipt of employee stock
bonus awards and the sale of the shares of Class A Common
26
Stock underlying such stock bonus awards, will have certain material income tax
implications for the distributors of NSI and the employees of the Company and
NSI. Although this Prospectus and related documentation contains certain tax
information relevant to distributors of NSI and employees of the Company and NSI
and its affiliates (other than the Company), such information is only intended
to be a summary of certain relevant provisions and does not address all aspects
of tax law that may be relevant to each distributor and employee based on the
individual circumstances of such distributor and employee in each jurisdiction
in which they operate. Distributors and employees are urged to consult their own
tax advisors with respect to the particular tax consequences to them of the
exercise of the Distributor Options and the purchase, ownership and disposition
of the Class A Common Stock, including the applicability of any federal, state,
provincial or foreign tax laws to which they may be subject as well as with
respect to the possible effects of changes in tax laws in each jurisdiction,
including changes which may be applied retroactively in a manner that could
adversely affect holders of the Class A Common Stock.
DESCRIPTION OF CAPITAL STOCK
General
As of the date of this Prospectus, the authorized capital stock of the
Company consists of 500,000,000 shares of Class A Common Stock, 100,000,000
shares of Class B Common Stock, and 25,000,000 shares of Preferred Stock. As of
March 5, 1998, the Company had 11,835,737 shares of Class A Common Stock issued
and outstanding and 70,280,759 shares of Class B Common Stock issued and
outstanding, all of which are held of record by the Original Stockholders and
certain of their affiliates. Of the authorized shares of Preferred Stock, no
shares of Preferred Stock were outstanding as of March 5, 1998; however, if the
NSI Acquisition is consummated, the Company will issue shares of Series A
Preferred Stock as partial consideration for NSI Acquisition. See "Recent
Developments" and "--Preferred Stock."
The following description of the Company's capital stock is a summary and
is subject to and qualified in its entirety by reference to the provisions of
the Company's Amended and Restated Certificate of Incorporation (the
"Certificate of Incorporation").
Common Stock
The approximate number of holders of record of the Company's Class A
Common Stock and Class B Common Stock as of March 5, 1998 was 895 and 63,
respectively. The shares of Class A Common Stock and Class B Common Stock are
identical in all respects, except for voting rights and certain conversion
rights and transfer restrictions regarding the shares of the Class B Common
Stock, as described below.
Voting Rights. Each share of Class A Common Stock entitles the holder to
one vote on each matter submitted to a vote of the Company's stockholders and
each share of Class B Common Stock entitles the holder to ten votes on each such
matter, including the election of directors. There is no cumulative voting.
Except as required by applicable law, holders of Class A Common Stock and
holders of Class B Common Stock will vote together on all matters submitted to a
vote of the stockholders. With respect to certain corporate changes, such as
liquidations, reorganizations, recapitalizations, mergers, consolidations and
sales of substantially all of the Company's assets, holders of Class A Common
Stock and holders of Class B Common Stock will vote together as a single class
and the approval of 662/3% of the outstanding voting power is required to
authorize or approve such transactions. See "Risk Factors--Control by Original
Stockholders; Anti-Takeover Effect of Dual Classes of Common Stock" and
"--Anti-Takeover Effects of Certain Charter, Contractual and Statutory
Provisions."
Any action that can be taken at a meeting of the stockholders may be taken
by written consent in lieu of a meeting if the Company receives consents signed
by stockholders having the minimum number of votes that would be necessary to
approve the action at a meeting at which all shares entitled to vote on the
matter were present. This could permit holders of Class B Common Stock to take
all actions required to be taken by the stockholders without providing the other
stockholders an opportunity to make nominations or raise other matters
27
at a meeting. The right to take action by less than unanimous written consent
expires at such time as there are no shares of Class B Common Stock outstanding.
Dividends. Holders of Class A Common Stock and holders of Class B Common
Stock are entitled to receive dividends at the same rate if, as and when such
dividends are declared by the Board of Directors of the Company out of assets
legally available therefor after payment of dividends required to be paid on
shares of Preferred Stock, if any.
If a dividend or distribution payable in Class A Common Stock is made on
the Class A Common Stock, the Company must also make a pro rata and simultaneous
dividend or distribution on the Class B Common Stock payable in shares of Class
B Common Stock. Conversely, if a dividend or distribution payable in Class B
Common Stock is made on the Class B Common Stock, the Company must also make a
pro rata and simultaneous dividend or distribution on the Class A Common Stock
payable in shares of Class A Common Stock. See "Risk Factors--Absence of
Dividends."
Restrictions on Transfer. If a holder of Class B Common Stock transfers
such shares, whether by sale, assignment, gift, bequest, appointment or
otherwise, to a person other than a permitted transferee (as defined in the
Company's Certificate of Incorporation) such shares will be converted
automatically into shares of Class A Common Stock. In the case of a pledge of
shares of Class B Common Stock to a financial institution, such shares will not
be deemed to be transferred unless and until a foreclosure occurs.
Conversion. The Class A Common Stock has no conversion rights. The Class B
Common Stock is convertible into shares of Class A Common Stock, in whole or in
part, at any time and from time to time at the option of the holder, on the
basis of one share of Class A Common Stock for each share of Class B Common
Stock converted. In the event of a transfer of shares of Class B Common Stock to
any person other than a "Permitted Transferee" (as defined in the Certificate of
Incorporation) each share of Class B Common Stock so transferred automatically
will be converted into one share of Class A Common Stock. Each share of Class B
Common Stock will also automatically convert into one share of Class A Common
Stock if, on the record date for any meeting of the stockholders, the number of
shares of Class B Common Stock then outstanding is less than 10% of the
aggregate number of shares of Class A Common Stock and Class B Common Stock then
outstanding.
Liquidation. In the event of liquidation, after payment of the debts and
other liabilities of the Company and after making provision for the holders of
Preferred Stock, if any, the remaining assets of the Company will be
distributable ratably among holders of Class A Common Stock and holders of Class
B Common Stock treated as a single class.
Mergers and Other Business Combinations. Upon the merger or consolidation
of the Company, holders of each class of Common Stock are entitled to receive
equal per share payments or distributions, except that in any transaction in
which shares of capital stock are distributed, such shares may differ as to
voting rights to the extent and only to the extent that the voting rights of the
Class A Common Stock and the Class B Common Stock (collectively, the "Common
Stock") differ at that time. The Company may not dispose of all or any
substantial part of the assets of the Company to, or merge or consolidate with,
any person, entity or "group" (as defined in Rule 13d-5 of the Exchange Act),
which beneficially owns in the aggregate 10% or more of the outstanding Common
Stock and Common Stock of the Company (a "Related Person") without the
affirmative vote of the holders, other than such Related Person, of not less
that 662/3% of the voting power of outstanding Class A Common Stock and Class B
Common Stock voting as a single class. For the sole purpose of determining the
662/3% vote, a Related Person will also include the seller or sellers from whom
the Related Person acquired, during the preceding six months, at least 5% of the
outstanding shares of Class A Common Stock in a single transaction or series of
related transactions pursuant to one or more agreements or other arrangements
(and not through a brokers' transaction), but only if such seller or sellers
have beneficial ownership of shares of Common Stock having a fair market value
in excess of $10 million in the aggregate following such disposition to such
Related Person. This 662/3% voting requirement is not applicable, however, if
(i) the proposed transaction is approved by
28
a vote of not less than a majority of the directors of the Company who are
neither affiliated nor associated with the Related Person (or the seller of
shares to the Related Person as described above) or (ii) in the case of a
transaction pursuant to which the holders of Common Stock are entitled to
receive cash, property, securities or other consideration, the cash or fair
market value of the property, securities or other consideration to be received
per share in such transaction is not less than the higher of (A) the highest
price per share paid by the Related Person for any of its holdings of Common
Stock within the two-year period immediately prior to the announcement of the
proposed transaction or (B) the highest closing sale price during the 30-day
period immediately preceding such date or during the 30-day period immediately
preceding the date on which the Related Person became a Related Person,
whichever is higher. See "Risk Factors--Anti-Takeover Effects of Certain
Charter, Contractual and Statutory Provisions."
Other Provisions. Holders of the Class A Common Stock and holders of Class
B Common Stock are not entitled to preemptive rights. Neither the Class A Common
Stock nor the Class B Common Stock may be subdivided or combined in any manner
unless the other class is subdivided or combined in the same proportion.
Transfer Agent and Registrar. The Transfer Agent and Registrar for the
Class A Common Stock is American Stock Transfer and Trust Company.
Listing. The Class A Common Stock is traded on the New York Stock Exchange
under the trading symbol "NUS." There is currently no public market for the
Class B Common Stock.
Preferred Stock
General
The Board of Directors is authorized, subject to any limitations
prescribed by the DGCL or the rules of the New York Stock Exchange or other
organizations on whose systems stock of the Company may be quoted or listed, to
provide for the issuance of additional shares of Preferred Stock in one or more
series, to establish from time to time the number of shares to be included in
each such series, to fix the rights, powers, preferences and privileges of the
shares of each wholly unissued series and any qualifications, limitations or
restrictions thereon, and to increase or decrease the number of shares of such
series, without any further vote or action by the stockholders. The approval of
the holders of at least 662/3% of the combined voting power of the outstanding
shares of Common Stock, however, is required for the issuance of shares of
Preferred Stock that have the right to vote for the election of directors under
ordinary circumstances or to elect 50% or more of the directors under any
circumstances. Depending upon the terms of the Preferred Stock established by
the Company's Board of Directors, any or all series of Preferred Stock could
have preference over the Common Stock with respect to dividends and other
distributions and upon liquidation of the Company or could have voting or
conversion rights that could adversely affect the holders of the outstanding
Common Stock. In addition, the Preferred Stock could delay, defer or prevent a
change of control of the Company. See "Risk Factors--Anti-Takeover Effects of
Certain Charter, Contractual and Statutory Provisions."
The NSI Acquisition
If the NSI Acquisition is consummated, the Company will issue shares of
Series A Preferred Stock as partial consideration for the NSI Acquisition.
Pursuant to the Acquisition Agreement, the number of shares of Series A
Preferred Stock to be issued will be determined by dividing $70 million by the
average closing price of the Class A Common Stock reported on the New York Stock
Exchange for the 20 consecutive trading days ending five trading days prior to
the closing of the NSI Acquisition.
To comply with certain rules and regulations of the New York Stock
Exchange, if the NSI Acquisition is consummated, the Certificate of Designation
setting forth the terms of the Series A Preferred Stock will provide that the
Series A Preferred Stock cannot be converted into Class A Common Stock until the
holders of the
29
Common Stock approve the issuance of Class A Common Stock upon conversion of the
Series A Preferred Stock or the requirements of the New York Stock Exchange are
otherwise satisfied to permit conversion thereof. The Company intends to submit
a proposal to the holders of Common Stock in connection with the Company's 1998
annual meeting of stockholders requesting the holders of Common Stock to approve
the issuance of shares of Class A Common Stock upon conversion of the Series A
Preferred Stock (the "Proposal").
If the NSI Acquisition is consummated and shares of Series A Preferred
Stock are issued, the Company anticipates that the Series A Preferred Stock will
have the following rights, powers, preferences and privileges.
Dividends. Prior to September 30, 1998, the holders of the Series A
Preferred Stock will share equally in any dividends declared, paid or set apart
for payment on the Common Stock or any other class or series of stock of the
Company ranking, as to dividends, on a parity with or junior to the Series A
Preferred Stock. At any time after September 30, 1998, if the holders of Common
Stock do not approve the Proposal and the requirements of the New York Stock
Exchange are not otherwise satisfied to permit conversion of the Series A
Preferred Stock to Class A Common Stock on or before such date, the holders of
the Series A Preferred Stock will be entitled to cash dividends after that date
at the rate of 7% of the "Preference Value" per share of Series A Preferred
Stock per annum (the "Cumulative Dividends"). The "Preference Value" will be
equal to 60% of the average closing price of the Class A Common Stock reported
on the New York Stock Exchange for the 20 consecutive trading days ending five
trading days prior to the closing of the NSI Acquisition. The Cumulative
Dividends must be paid in full before any dividends can be paid on securities
ranking junior to the Series A Preferred Stock (including the Common Stock). The
Cumulative Dividends will be payable in quarterly installments on each March 31,
June 30, September 30 and December 31, commencing December 31, 1998. The
Cumulative Dividends will accrue (whether or not declared) from September 30,
1998 and accrued Cumulative Dividends will accumulate to the extent not paid in
a quarterly dividend period.
Liquidation Preference. The Series A Preferred Stock will have a
liquidation preference equal to the Preference Value. Upon the liquidation,
dissolution or winding up of the Company, holders of the Series A Preferred
Stock will be entitled to the Preference Value per share of the Series A
Preferred Stock plus any accrued and unpaid dividends on the Series A Preferred
Stock (collectively, the "Series A Liquidation Preference") prior to any payment
being made to holders of the Common Stock or any stock of the Company junior to
the Series A Preferred Stock. In the event there are sufficient assets to pay
the full Series A Liquidation Preference, any remaining assets will first be
distributed to the holders of the Common Stock in a total amount equal to the
Series A Liquidation Preference and will thereafter be distributed to the
holders of the Common Stock and the holders of the Series A Preferred Stock pro
rata based on the number of shares held by each holder. The sale of all or
substantially all of the assets of the Company or the consolidation or merger of
the Company with another entity will be deemed to be a liquidation, dissolution
or winding up of the Company for purposes of the Series A Liquidation
Preference.
Optional Redemption by the Company. The Series A Preferred Stock will be
redeemable by the Company at its option in whole, but not in part, at any time
after September 30, 1998, if the stockholders do not approve the Proposal or the
requirements of the New York Stock Exchange are not otherwise satisfied to
permit conversion of the Series A Preferred Stock to Class A Common Stock on or
before such date. If these redemption provisions were triggered, the redemption
price per share would be equal to the lesser of (i) the Preference Value or (ii)
60% of average of the last sales prices per share of the Class A Common Stock of
the Company on the New York Stock Exchange for the 20 consecutive trading days
ending on the trading day which is five trading days prior to the redemption
date. The redemption price would be payable 25% in cash on the redemption date
and the remaining 75% in promissory notes. The principal on the promissory notes
would be payable in three equal annual installments on the anniversary of the
redemption date in each of the next three succeeding years, with interest on the
unpaid principal balance payable at a rate per annum equal to the short term
applicable federal rate as defined in the Code.
30
Voting Rights. Holders of Series A Preferred Stock generally will have no
voting rights. However, a vote or consent of 662/3% of the outstanding Series A
Preferred Stock will be required for the Company to issue any class or series of
stock ranking prior to or on a parity with the Series A Preferred Stock with
respect to dividends or distribution of assets upon liquidation or for the
Company to amend its Certificate of Incorporation so as to materially and
adversely affect the rights and preferences of the Series A Preferred Stock. In
addition, holders of Series A Preferred Stock will have the right to elect two
new members of the Board of Directors if the right to receive Cumulative
Dividends has been triggered and such Cumulative Dividends are in arrears in an
amount equal to or greater than six quarterly Cumulative Dividends.
Automatic Conversion. If the Proposal is approved by the holders of Common
Stock, the outstanding shares of Series A Preferred Stock will be automatically
converted into Class A Common Stock at the Conversion Ratio (as defined in the
Certificate of Designation) then in effect. The Conversion Ratio initially will
be one share of Class A Common Stock per share of Series A Preferred Stock, and
will be subject to adjustment for dilutive issuances of securities.
Right to Redeem the Class A Common Stock Issuable Upon Conversion of
Series A Preferred Stock. If the holders of Common Stock approve the Proposal,
pursuant to the NSI Acquisition Agreement the Company will have the right to
redeem the Class A Common Stock issued upon conversion of the Series A Preferred
Stock. Subject to the limitations described below, the redemption price per
share will initially be the average closing price of the Class A Common Stock
reported on the New York Stock Exchange for the 20 consecutive trading days
ending five trading days prior to the closing of the NSI Acquisition, and will
increase on each anniversary date of the issuance of the Class A Common Stock as
follows:
Date Redemption Price
---- ----------------
Issuance 100%
First Anniversary 120%
Second Anniversary 140%
Third Anniversary 160%
Fourth Anniversary 180%
Fifth Anniversary 200%
The redemption right expires on the sixth anniversary of the issuance of the
Class A Common Stock upon conversion of the Series A Preferred Stock. In order
for the redemption right to be exercised, the redemption price must be no more
than 100% of the average of the last sales prices per share of the Class A
Common Stock of the Company on the New York Stock Exchange for the 20
consecutive trading days ending on the trading date that is five trading days
prior to the date of the redemption. In addition, in order for such redemption
right to be exercised, at least two-thirds of the independent members of the
Board of Directors must approve the redemption after consideration of relevant
alternate cash investments available to the Company at that time.
Other Charter and Bylaw Provisions
Special meetings of stockholders may be called only by the majority
stockholders, the Board of Directors or the President or Secretary of the
Company. Except as otherwise required by law, stockholders, in their capacity as
such, are not entitled to request or call a special meeting of the stockholders.
Stockholders of the Company are required to provide advance notice of
nominations of directors to be made at, and of business proposed to be brought
before, a meeting of the stockholders. The failure to deliver proper notice
within the periods specified in the Company's Amended and Restated Bylaws (the
"Bylaws") will result in the denial of the stockholder of the right to make such
nominations or propose such action at the meeting. See "Risk
Factors--Anti-Takeover Effects of Certain Charter, Contractual and Statutory
Provisions."
31
Section 203 of the Delaware General Corporation Law
The Company is a Delaware corporation and is subject to the provisions of
Section 203 of the DGCL (the "Anti-Takeover Law") regulating corporate
takeovers. The Anti-Takeover Law prevents certain Delaware corporations,
including those whose securities are listed on the New York Stock Exchange, from
engaging, under certain circumstances, in a "business combination" with an
"interested stockholder" (a stockholder who, together with affiliates and
associates, within the prior three years did own 15% or more of the
corporation's outstanding voting stock) for three years following the date that
such stockholder became an "interested stockholder," unless the "business
combination" or "interested stockholder" is approved in a prescribed manner. A
Delaware corporation may "opt out" of the Anti-Takeover Law with an express
provision in its original certificate of incorporation or an express provision
in its certificate of incorporation or bylaws resulting from a stockholders'
amendment approved by at least a majority of the outstanding voting shares. The
Company has not "opted out" of the provisions of the Anti-Takeover Law. See
"Risk Factors--Anti-Takeover Effects of Certain Charter, Contractual and
Statutory Provisions."
Indemnification and Limitation of Liability of Directors and Officers
To the fullest extent permitted by the DGCL, the Company's Certificate of
Incorporation and Bylaws provide that the Company shall indemnify and advance
expenses to each of its directors, officers, employees and agents. The Company
believes the foregoing provisions are necessary to attract and retain qualified
persons as directors and officers. The Company has entered into separate
indemnification agreements with each of its directors and executive officers in
order to effectuate such provisions. The Company's Certificate of Incorporation
also provides for, to the fullest extent permitted by the DGCL, elimination or
limitation of liability of directors for breach of their fiduciary duty to the
Company or its stockholders.
Registration Rights
Under the Stockholders' Agreement, the Original Stockholders have been
granted registration rights by the Company permitting each of such Original
Stockholders to register his or her shares of Class A Common Stock, subject to
certain restrictions, on any registration statement filed by the Company until
such Original Stockholder has sold a specified value of shares of Class A Common
Stock.
CERTAIN UNITED STATES TAX CONSEQUENCES
TO NON-UNITED STATES HOLDERS
The following is a general discussion of certain United States federal
income and estate tax consequences of the ownership and disposition of Class A
Common Stock by a Non-U.S. Holder. For this purpose, a "Non-U.S. Holder" is any
person who is, for United States federal income tax purposes, a foreign
corporation, a non-resident alien individual, a foreign partnership or a foreign
estate or any trust unless a court within the United States is able to exercise
primary supervision over the administration of the trust and one or more United
States persons has the authority to control all substantial decisions over the
trust. This discussion does not address all material aspects of United States
federal income and estate taxes and does not deal with foreign, state and local
consequences that may be relevant to such Non-U.S. Holders in light of their
personal circumstances. Furthermore, this discussion is based on provisions of
the Code, existing and proposed regulations promulgated thereunder and
administrative and judicial interpretations thereof, as of the date hereof, all
of which are subject to change (possibly with retroactive effect). Each
prospective purchaser of Class A Common Stock is advised to consult a tax
advisor with respect to current and possible future tax consequences of
acquiring, holding and disposing of Class A Common Stock as well as any tax
consequences that may arise under the laws of any foreign or U.S. state,
municipality or other taxing jurisdiction.
An individual may, subject to certain exceptions, be deemed to be a
resident alien (as opposed to a non-resident alien) by virtue of being present
in the United States for 183 days or more during the calendar year
32
or on at least 31 days in the calendar year and for an aggregate of at least 183
days during a three-year period ending in the current calendar year (counting
for such purposes all of the days present in the current year, one-third of the
days present in the immediately preceding year, and one-sixth of the days
present in the second preceding year). Resident aliens are subject to U.S.
federal tax as if they were U.S. citizens.
Dividends
Dividends paid to a Non-U.S. Holder of Class A Common Stock generally will
be subject to withholding of United States federal income tax either at a rate
of 30% of the gross amount of the dividends or at such lower rate as may be
specified by an applicable income tax treaty. However, dividends that are
effectively connected with the conduct of a trade or business by the Non-U.S.
Holder within the United States and, where a tax treaty applies, are
attributable to a United States permanent establishment of the Non-U.S. Holder,
are not subject to the withholding tax (provided the Non-U.S. Holder files
appropriate documentation, including, under current law, IRS Form 4224, with the
payor of the dividend), but instead are subject to United States federal income
tax on a net income basis at applicable graduated individual or corporate rates.
Any such effectively connected dividends received by a foreign corporation may,
under certain circumstances, be subject to an additional "branch profits tax" at
a 30% rate or such lower rate as may be specified by an applicable income tax
treaty.
Under United States Treasury regulations that apply to dividends paid
before January 1, 1999, dividends paid to an address outside the United States
are presumed to be paid to a resident of such country (unless the payer has
knowledge to the contrary) for purposes of the withholding discussed above and
for purposes of determining the applicability of a tax treaty rate. Under United
States Treasury regulations that apply to dividends paid after December 31,
1998, a Non-U.S. Holder of Class A Common Stock wishing to claim the benefit of
an applicable treaty rate will be required to satisfy applicable certification
and other requirements either directly or through an intermediary. In addition,
backup withholding, as discussed below, may apply in certain circumstances if
applicable certification and other requirements are not met.
Gain on Disposition of Common Stock
A Non-U.S. Holder will generally not be subject to United States federal
income tax with respect to gain recognized on a sale or other disposition of
Class A Common Stock unless (i) the gain is effectively connected with a trade
or business of the Non-U.S. Holder in the United States, and, where a tax treaty
applies, is attributable to a United States permanent establishment of the
Non-U.S. Holder, (ii) in the case of a Non-U.S. Holder who is an individual and
holds the Class A Common Stock as a capital asset, such holder is present in the
United States for 183 or more days in the taxable year of the sale or other
disposition and certain other conditions are met, or (iii) the Company is or has
been a "U.S. real property holding corporation" for United States federal income
tax purposes. The Company believes it is not and does not anticipate becoming a
"U.S. real property holding corporation" for United States federal income tax
purposes.
If an individual Non-U.S. Holder falls under clause (i) above, he will,
unless an applicable treaty provides otherwise, be taxed on his net gain derived
from the sale under regular graduated United States federal income tax rates. If
an individual Non-U.S. Holder falls under clause (ii) above, he will be subject
to a flat 30% tax on the gain derived from the sale, which may be offset by
certain United States capital losses.
If a Non-U.S. Holder that is a foreign corporation falls under clause (i)
above, it will be taxed on its gain under regular graduated United States
federal income tax rates and may be subject to an additional branch profits tax
at a 30% rate, unless it qualifies for a lower rate under an applicable income
tax treaty.
33
Federal Estate Tax
Class A Common Stock held by an individual Non-U.S. Holder at the time of
death will be included in such holder's gross estate for United States federal
estate tax purposes, unless an applicable estate tax treaty provides otherwise.
Information Reporting and Backup Withholding Tax
The Company must report annually to the IRS and to each Non-U.S. Holder
the amount of dividends paid to such holder and the tax withheld with respect to
such dividends, regardless of whether withholding was required. Copies of the
information returns reporting such dividends and withholding may also be made
available to the tax authorities in the country in which the Non-U.S. Holder
resides under the provisions of an applicable income tax treaty.
A backup withholding tax is imposed at the rate of 31% on certain payments
to persons that fail to furnish certain identifying information to the payor
under the United States information reporting requirements. Under United States
Treasury regulations that apply to dividends paid before January 1, 1999, backup
withholding generally will not apply to dividends paid to a Non-U.S. Holder at
an address outside the United States (unless the payer has knowledge that the
payee is a U.S. person), but generally will apply to dividends paid on Class A
Common Stock at addresses inside the United States to Non-U.S. Holders that fail
to provide certain identifying information in the manner required. Under
Treasury regulations that apply to dividends paid after December 31, 1998, a
Non-U.S. Holder generally would be subject to backup withholding at a 31% rate,
unless certain certification procedures (or, in the case of payments made
outside the United States with respect to an offshore account, certain
documentary evidence procedures) are complied with, directly or through an
intermediary or a Non-U.S. Holder otherwise establishes an exemption from backup
withholding.
Payment of the proceeds of a sale of Class A Common Stock by or through a
United States office of a broker is subject to both backup withholding and
information reporting unless the beneficial owner provides the payor with its
name and address and certifies under penalties of perjury that it is a Non-U.S.
Holder, or otherwise establishes an exemption. In general, backup withholding
and information reporting will not apply to a payment of the proceeds of a sale
of Class A Common Stock by or through a foreign office of a foreign broker. If,
however, such broker is, for United States federal income tax purposes a U.S.
person, a controlled foreign corporation, or a foreign person that derives 50%
or more of its gross income for certain periods from the conduct of a trade or
business in the United States, such payments will be subject to information
reporting, but not backup withholding, unless (i) such broker has documentary
evidence in its records that the beneficial owner is a Non-U.S. Holder and
certain other conditions are met, or (ii) the beneficial owner otherwise
establishes an exemption.
Any amounts withheld under the backup withholding rules generally will be
allowed as a refund or a credit against such holder's U.S. federal income tax
liability provided the required information is furnished in a timely manner to
the IRS.
LEGAL MATTERS
The validity of the issuance of the shares of Class A Common Stock offered
hereby will be passed upon for the Company and the Rule 415 Selling Stockholders
by LeBoeuf, Lamb, Greene & MacRae, L.L.P., a limited liability partnership
including professional corporations, Salt Lake City, Utah.
EXPERTS
The consolidated financial statements incorporated in this Prospectus by
reference to the Nu Skin Asia Pacific, Inc. Annual Report on Form 10-K for the
year ended December 31, 1997 have been so incorporated in reliance on the report
of Price Waterhouse LLP, independent accountants, given on authority of said
firm as experts in auditing and accounting.
34
- ------------------------------------------------------------------------------
No person is authorized to give any information or make any representations
other than those contained in this Prospectus and, if given or made, such
information or representations must not be relied upon as having been authorized
by the Company, any Rule 415 Selling Stockholder or any other person. This
Prospectus does not constitute an offer to sell or a solicitation of any offer
to purchase any securities other than those to which it relates or an offer to
sell or a solicitation of an offer to purchase any securities in any
jurisdiction where such an offer or solicitation would be unlawful. Neither the
delivery of this Prospectus nor any distribution of securities hereunder shall
under any circumstances be deemed to imply that there has been no change in the
assets, properties or affairs of the Company since the date hereof or that the
information set forth herein is correct as of any time subsequent to the date
hereof.
-------------------
TABLE OF CONTENTS Page
----
Available Information.........................................................2
Incorporation by Reference....................................................2
Forward-Looking Statements....................................................3
The Company...................................................................4
Recent Developments...........................................................5
Risk Factors..................................................................8
Use of Proceeds..............................................................23
Rule 415 Selling Stockholders................................................23
Plan of Distribution.........................................................24
Description of Capital Stock.................................................27
Certain United States Tax Consequences to Non-United States Holders..........32
Legal Matters................................................................34
Experts......................................................................34
-------------------
3,030,000 Shares
[LOGO]
Class A Common Stock
---------------
PROSPECTUS
---------------
March ___, 1998
---------------
Part II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution.
The estimated expenses of the issuance and distribution are as follows:
SEC Registration Fee.............................................. $80,406*
NASD Fee.......................................................... 27,117*
NYSE Listing Fee.................................................. 109,000*
Printing and Engraving Expenses................................... 595,000**
Accounting Fees and Expenses...................................... 315,000**
Legal Fees and Expenses........................................... 815,000**
Blue Sky Fees and Expenses........................................ 15,000*
Transfer Agent's Fees and Expenses................................ 10,000**
Miscellaneous Expenses............................................ 165,000*
------------
Total.......................................................... $2,131,523**
- -----------
* The securities offered hereby were registered under the Securities Act in
connection with the Company's underwritten initial public offering in
November 1996 (the "Underwritten Offerings"). Accordingly, the indicated
fees and expenses were incurred and paid in connection with the Underwritten
Offerings. The expenses of the Rule 415 Offerings will be paid by the Rule
415 Selling Stockholders.
** The indicated fees and expenses include certain fees and expenses paid in
connection with the Underwritten Offerings.
Item 15. Indemnification of Directors and Officers.
Article 10 of the Company's Certificate of Incorporation and Article 5 of
the Company's Bylaws require indemnification to the fullest extent permitted by
Section 145 of DGCL. Section 145 of the DGCL provides that a corporation may
indemnify directors and officers as well as other employees and individuals
against expenses (including attorneys' fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred in connection with specified
actions, suits or proceedings, whether civil, criminal, administrative, or
investigative (other than action by or in the right of the corporation a
"derivative action"), if they acted in good faith and in a manner they
reasonably believed to be in or not opposed to the best interests of the
corporation and, with respect to any criminal action or proceeding, had no
reasonable cause to believe their conduct was unlawful. A similar standard is
applicable in the case of derivative actions, except that indemnification only
extends to expenses (including attorneys' fees) incurred in connection with the
defense or settlement of such actions, and the statute requires court approval
before there can be any indemnification where the person seeking indemnification
has been found liable to the corporation. Indemnification provided by or granted
pursuant to Section 145 of the DGCL is not exclusive of other indemnification
that may be granted by a corporation's bylaws, any agreement, any vote of
stockholders or disinterested directors or otherwise. Article 5 of the Company's
Bylaws provides for indemnification consistent with the requirements of Section
145 of the DGCL.
Section 145 of the DGCL also permits a corporation to purchase and maintain
insurance on behalf of directors and officers. Article 5 of the Company's Bylaws
permits it to purchase such insurance on behalf of its directors and officers.
Article 7 of the Company's Certificate of Incorporation provides for, to the
fullest extent permitted by the DGCL, elimination or limitation of liability of
directors to the Company or its stockholders for breach of fiduciary duty as a
director. Section 102(b)(7) of the DGCL permits a corporation to provide in its
certificate of
II-1
incorporation that a director of the corporation shall not be personally liable
to the corporation or its stockholders for monetary damages for breach of
fiduciary duties as a director, except for liability (i) for any breach of a
director's duty of loyalty to the corporation or its stockholders; (ii) for acts
or omissions not in good faith or which involve international misconduct or a
knowing violation of law; (iii) for improper payment of dividends or redemptions
of shares; or (iv) for any transaction from which the director derives an
improper personal benefit.
Item 16. Exhibits and Financial Statements Schedules.
*4.1 Specimen Form of Stock Certificate for Class A Common Stock
*5.1 Opinion of LeBoeuf, Lamb, Greene & MacRae, L.L.P. regarding legality of
the securities covered by this Registration Statement
23.1 Consent of Price Waterhouse LLP, independent accountants
*23.2 Consent of LeBoeuf, Lamb, Green & MacRae, L.L.P. (included in legal
opinion--see Exhibit 5.1)
*24 Power of Attorney (included with the signatures in Part II of this
Registration Statement)
- -----------
* Filed previously.
Item 17. Undertakings.
(a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement:
(i) To include any prospectus required by Section 10 (a) (3) of
the Securities Act of 1933.
(ii) To reflect in the prospectus any facts or events arising
after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate,
represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of
securities offered (if the total dollar value of securities offered would not
exceed that which was registered) and any deviation from the low or high end of
the estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424 (b) if, in the aggregate, the
changes in volume and price represent no more than a 20% change in the maximum
aggregate offering price set forth in the "Calculation of Registration Fee"
table in the effective registration statement.
(iii) To include any material information with respect to the
plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement.
Provided, however, that paragraphs (a) (1) (i) and (a) (1) (ii) do not
apply if the registration statement is on Form S-3 or Form S-8, and the
information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed by the registrant pursuant to
Section 13 or Section 15 (d) of the Securities and Exchange Act of 1934 that are
incorporated by reference in the registration statement.
(2) That, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
II-2
(3) To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the termination of
the offering.
(b) The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the
Registrant's annual report pursuant to Section 13 (a) or Section 15 (d) of the
Securities Exchange Act of 1934 (and, where applicable, each filing of an
employee benefit plan's annual report pursuant to Section 15 (d) of the
Securities Exchange Act of 1934) that is incorporated by reference in the
registration statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors, officers and controlling persons of
the Registrant pursuant to the foregoing provisions, or otherwise, the
Registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the
Securities Act of 1933 and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than the payment by
the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the
Securities Act of 1933 and will be governed by the final adjudication of such
issue.
II-3
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Provo, State of Utah, on March 17, 1998.
NU SKIN ASIA PACIFIC, INC.
By:
--------------------------------------
Steven J. Lund
President and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, as amended, this
Registration Statement on Form S-3 has been signed below on March 17, 1998 by
the following persons in the capacities indicated.
Signature Title Date
----------- ------- ------
* Chairman of the Board March 17, 1998
- ---------------------------------- of Directors
Blake M. Roney
/s/ STEVEN J. LUND President and Chief Executive March 17, 1998
- ---------------------------------- Officer and Director
Steven J. Lund (Principal Executive Officer)
* Chief Financial Officer March 17, 1998
- ---------------------------------- (Principal Financial and
Corey B. Lindley Accounting Officer)
* Director March 17, 1998
- ----------------------------------
Sandra N. Tillotson
* Director March 17, 1998
- ----------------------------------
Keith R. Halls
* Director March 17, 1998
- ----------------------------------
Brooke B. Roney
* Director March 17, 1998
- ----------------------------------
Max L. Pinegar
* Director March 17, 1998
- ----------------------------------
E.J. "Jake" Garn
II-4
Signature Title Date
----------- ------- ------
* Director March 17, 1998
- ----------------------------------
Paula Hawkins
* Director March 17, 1998
- ----------------------------------
Daniel W. Campbell
* By: /S/ STEVEN J. LUND March 17, 1998
- ----------------------------------
Steven J. Lund
Attorney-in-Fact
II-5
INDEX TO EXHIBITS
Exhibit
Number Exhibit Description
- ------- -------------------
*4.1 Specimen Form of Stock Certificate for Class A Common Stock
*5.1 Opinion of LeBoeuf, Lamb, Greene & MacRae, L.L.P. regarding legality of
the securities covered by this Registration Statement
23.1 Consent of Price Waterhouse LLP, independent accountants
*23.2 Consent of LeBoeuf, Lamb, Green & MacRae, L.L.P. (included in legal
opinion--see Exhibit 5.1)
*24 Power of Attorney (included with the signatures in Part II of this
Registration Statement)
- -----------
* Filed previously.
II-6